Form 10-Q Quarterly Report

0001078782-16-003778.txt : 20161114 0001078782-16-003778.hdr.sgml : 20161111 20161114153222 ACCESSION NUMBER: 0001078782-16-003778 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FRESH MEDICAL LABORATORIES, INC. CENTRAL INDEX KEY: 0001541884 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 201922768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54600 FILM NUMBER: 161994289 BUSINESS ADDRESS: STREET 1: 757 EAST SOUTH TEMPLE, SUITE 150 CITY: SALT LAKE CITY STATE: UT ZIP: 84102 BUSINESS PHONE: 801-204-9623 MAIL ADDRESS: STREET 1: 757 EAST SOUTH TEMPLE, SUITE 150 CITY: SALT LAKE CITY STATE: UT ZIP: 84102 10-Q 1 f10q093016_10q.htm FORM 10-Q QUARTERLY REPORT Form 10-Q Quarterly Report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

X .

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2016

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ___________ to ______________

Commission file number: 000-54600

FRESH MEDICAL LABORATORIES, INC.

(Exact name of registrant as specified in its charter)


Delaware		20-1922768
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)


757 East South Temple, Suite 150
Salt Lake City, Utah		84102
(Address of principal executive offices)		(Zip Code)

(801) 736–0729

(Registrant’s telephone number, including area code)

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X . No .

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes X . No .

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	.	Accelerated filer	.
Non-accelerated filer	. (Do not check if a smaller reporting company)	Smaller reporting company	X .

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes .No X .

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of November 14, 2016, the issuer had 22,810,870 shares of Common Stock, $0.001 par value, outstanding.

FRESH MEDICAL LABORATORIES, INC.

TABLE OF CONTENTS



	Part I – Financial Information
Item 1	Financial Statements	3
	Condensed Consolidated Balance Sheets (Unaudited), September 30, 2016 and December 31, 2015	3
	Condensed Consolidated Statements of Operations (Unaudited) for the Three and Nine months Ended September 30, 2016 and 2015	4
	Condensed Consolidated Statements of Cash Flows (Unaudited) for the Nine months Ended September 30, 2016 and 2015	5
	Notes to the Unaudited Condensed Consolidated Financial Statements	6
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3	Quantitative and Qualitative Disclosures about Market Risk	18
Item 4	Controls and Procedures	18

	Part II – Other Information
Item 1	Legal Proceedings	19
Item 1A	Risk Factors	19
Item 2	Unregistered Sales Of Equity Securities And Use Of Proceeds	19
Item 3	Defaults Upon Senior Securities	19
Item 4	Mine Safety Disclosures	19
Item 5	Other Information	19
Item 6	Exhibits	20

Signatures		21

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS


Fresh Medical Laboratories, Inc. and Subsidiary
Condensed Consolidated Balance Sheets
(Unaudited)
			September 30,		December 31,
			2016		2015
Assets
Current Assets
	Cash	$	41,236	$	451,526
	Accounts receivable, net of allowance for doubtful accounts of $0 and $194,467, respectively		-		-
	Inventory		35,174		35,174
	Prepaid expenses		3,556		30,520
Total Current Assets			79,966		517,220

Inventory, noncurrent			358,908		206,722
Property and equipment, net of accumulated depreciation			88,823		106,541
Intangible assets, net of accumulated amortization			168,129		175,300

Total Assets		$	695,826	$	1,005,783

Liabilities and Stockholders' Equity (Deficit)
Current Liabilities
	Accounts payable	$	328,155	$	97,849
	Accrued liabilities		240,896		138,683
	Related-party notes payable		155,000		25,000
	Current Note Payable		32,000		189,389
Total Current Liabilities			756,051		450,921

Long-Term Liabilities
	Note Payable		189,389		-
	Convertible notes payable		1,206,931		1,206,931
	Convertible debentures		1,282,050		2,000,000
Total Long-Term Liabilities			2,678,370		3,206,931

Total Liabilities			3,434,421		3,657,852

Stockholders' Equity (Deficit):
	Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding		-		-
	Common stock, $0.001 par value; 40,000,000 shares authorized; 23,477,787 shares and 21,525,126 shares issued and outstanding, respectively		23,479		21,525
	Additional paid-in capital		12,634,261		10,636,583
	Accumulated deficit		(15,396,335)		(13,310,177)
Total Stockholders' Equity (Deficit)			(2,738,595)		(2,652,069)

Total Liabilities and Stockholders' Equity (Deficit)		$	695,826	$	1,005,783

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


Fresh Medical Laboratories, Inc. and Subsidiary
Condensed Consolidated Statements of Operations
(Unaudited)
			For the Three Months Ended				For the Nine Months Ended
			September 30,				September 30,
			2016		2015		2016		2015
Revenues:
	Revenue	$	-	$	10,450	$	-	$	19,450

	Total revenue		-		10,450		-		19,450

Cost of revenue			-		7,763		10,193		15,563

Gross margin			-		2,687		(10,193)		3,887

Operating expenses:
	Research and development expense		241,809		389,851		806,052		877,552
	Selling, general and administrative expense		360,172		398,218		1,065,631		836,974
	Total operating expenses		601,981		788,069		1,871,683		1,714,526

Loss from operations			(601,981)		(785,382)		(1,881,876)		(1,710,639)

Other income (expense):
	Interest expense		(65,526)		(79,004)		(204,282)		(193,412)
	Foreign currency exchange gain (loss), net		-		(2,331)		-		(22,287)
	Total other income (expense)		(65,526)		(81,335)		(204,282)		(215,699)

	Net loss	$	(667,507)	$	(866,717)	$	(2,086,158)	$	(1,926,338)

	Basic and diluted loss per share	$	(0.03)	$	(0.04)	$	(0.09)	$	(0.10)

	Weighted-average common shares outstanding, basic and diluted		22,964,764		20,448,611		22,349,903		20,013,387

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


Fresh Medical Laboratories, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows
(Unaudited)
				For the Nine Months Ended
				September 30,
				2016		2015
Cash flows from operating activities:
	Net loss		$	(2,086,158)	$	(1,926,338)
	Adjustments to reconcile net loss to net cash used in operating activities:
		Depreciation & Amortization		24,889		6,767
		Stock-based compensation		302,590		238,765
		Obsolete inventory		10,193		-
		Stock issued for services		29,651		-
		Provision for Doubtful Accounts		-		47,815
		Change in assets and liabilities:
		Accounts receivable		-		50,711
		Inventory		(162,379)		1,092
		Prepaid expenses		26,964		5,384
		Accounts payable		230,306		(6,235)
		Accrued Liabilities		169,430		(121,560)
Net cash flows from operating activities				(1,454,514)		(1,703,599)

Cash flows from investing activities:
	Payments for property and equipment			-		(62,619)
Net cash flows from investing activities				-		(62,619)

Cash flows from financing activities:
	Issuance of common stock for cash			882,224		807,960
	Proceeds from issuance of convertible debentures			-		2,000,000
	Payments on convertible notes payable			-		(40,000)
	Payments on notes payable			-		(29,536)
	Proceeds from notes payable			32,000		-
	Proceeds from related party debt			185,000		-
	Payments on related party debt			(55,000)		-
Net cash flows from financing activities				1,044,224		2,738,424

Net increase (decrease) in cash				(410,290)		972,206
Cash at beginning of period				451,526		4,044
Cash at end of period			$	41,236	$	976,250

Supplemental disclosure of cash flow information:
	Cash paid for interest		$	48,744	$	309,658
	Cash paid for income taxes		$	-	$	-

Supplemental disclosure of non-cash investing and financing activities:
	Conversion of convertible debt and interest		$	785,167	$	61,935
	Stock issued to placement agent		$	66	$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Fresh Medical Laboratories, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1 – Organization and Summary of Significant Accounting Policies

Organization – Fresh Medical Laboratories, Inc. (the “Company”) is a Delaware corporation that was incorporated on November 22, 2004 and is doing business as “ProLungdx”. The Company’s headquarters are located in Salt Lake City, Utah. The Company’s business is the development and deployment of medical devices and procedures specializing in the immediate, non-invasive evaluation of indeterminate lung masses suspicious for cancer as seen in CT and radiography. The Company’s principal activities have consisted of research and development, developing markets for its products, securing strategic alliances and obtaining financing. The Company has developed and tested, and is commercializing its non-invasive lung cancer risk stratification test, the “Electro Pulmonary Nodule Scan” (“EPN Scan”). In April 2013, the Company entered into an agreement to license this technology to a distributor for the China market. In May 2013, the Company received the “CE” mark in Europe permitting the marketing of the EPN Scan in the European Union and certain other countries. During the year ended December 31, 2014, the Company commenced selling the EPN Scan to customers in the European Union. In the United States, the Company has submitted its application for marketing approval to the United States Food and Drug Administration but has since withdrawn such application with the intent of re-submitting it once certain tests are complete.

Principles of Consolidation – During the year ended December 31, 2012, the Company formed a wholly-owned subsidiary, Hilltop Acquisition Corporation, Inc., which has had no activity since its inception and is included in the accompanying condensed consolidated financial statements from the date of its formation.

Going Concern – The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has commenced selling the EPN Scan in Europe and to a licensee for China, but has generated minimal revenues thus far from operations. Therefore, the Company has not yet achieved its planned level of operations. The Company has incurred substantial and recurring losses to date from operations, and has used cash in its operating activities during the nine months ended September 30, 2016 and 2015. Additionally, the Company had a stockholders’ deficit as of September 30, 2016. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result relating to the recoverability and classification of the asset carrying amounts or the amount and classification of liabilities that might result from the outcome of this risk and uncertainty.

The ability of the Company to continue as a going concern is dependent on the Company successfully developing products that can be sold profitably, and in the near term successfully generating cash through financing and operating activities. Management’s plans include issuing equity or debt securities to fund capital requirements and ongoing operations. Additionally, the Company commenced selling the EPN Scan during the year ended December 31, 2014. However, there can be no assurance the Company will be successful in these efforts.

Basis of Presentation – The accompanying condensed consolidated financial statements have been prepared by management in accordance with rules and regulations promulgated by the U.S. Securities and Exchange Commission and therefore certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments necessary for them to be presented fairly, with those adjustments consisting only of normal recurring adjustments. These interim financial statements should be read in conjunction with the Company’s annual consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2015. The results of operations for the nine months ended September 30, 2016 may not be indicative of the results to be expected for the year ending December 31, 2016.

Basic and Diluted Loss Per Share – The Company computes basic loss per share by dividing net loss by the weighted-average number of common shares outstanding during the period. The Company computes diluted loss per share by dividing net loss by the sum of the weighted-average number of common shares outstanding and the weighted-average dilutive common share equivalents outstanding. The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect. As of September 30, 2016 and 2015, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:

Fresh Medical Laboratories, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)


	For the Three and Nine Months Ended
	September 30,
	2016	2015
Warrants to purchase shares	1,423,211	1,423,211
Non-vested shares	10,871	505,634
Convertible debentures	2,204,068	3,076,923
Convertible notes	1,641,692	-

Recent Accounting Pronouncements –

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (ASU 2016-02). ASU 2016-02 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. ASU 2016-02 will be effective for the Company’s fiscal year beginning January 1, 2019 on a modified retrospective basis and earlier adoption is permitted. Management is currently evaluating the impact of the pending adoption of ASU 2016-02 on the Company’s consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (“ASU 2016-09”), which simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 will be effective for annual periods beginning after December 15, 2016 and interim periods within those annual periods. It is not anticipated that this update will have a material effect on the Company’s consolidated financial statements.

Note 2 – Inventory

Inventory valued at $10,193 was written off during the nine months ended September 30, 2016 due to obsolescence and is reported as cost of revenues in the accompanying statement of operations. Inventory consists of the following:


		September 30,		December 31,
		2016		2015

Raw materials	$	93,792	$	76,925
Work in progress		49,146		58,376
Finished goods		251,144		106,595

Total inventory		394,082		241,896

Less carrying value of inventory not deemed to be a current asset		358,908		206,722

Inventory, included in current assets	$	35,174	$	35,174

Note 3 – Accrued Liabilities

Accrued liabilities consisted of the following:


		September 30,		December 31,
		2016		2015

Accrued interest	$	203,798	$	115,627
Accrued royalties		17,873		17,873
Accrued payroll and payroll taxes		19,225		5,183

Total accrued liabilities	$	240,896	$	138,683

Fresh Medical Laboratories, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 4 –Short and Long-term Debt

Short and Long-term debt is summarized as follows:


		September 30,		December 31,
		2016		2015

Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018; $717,950 was converted to stock during the nine months ended September 30, 2016	$	1,282,050	$	2,000,000

Convertible notes payable; unsecured; interest at 8.00% per annum; due November 6, 2020		1,206,931		1,206,931

Note payable secured by all the assets of the Company; interest at 15.00% per annum; due June 30, 2018		189,389		189,389

Note payable; interest at 10.00% per annum; due December 24, 2016		32,000		-

Short term related-party bridge loans; unsecured; interest at 8-10% per annum; due December 24, 2016		155,000		-

Related-party note payable; interest at 8%; due August 31, 2016		-		25,000

Total long-term debt		2,865,370		3,421,320

Less: current portion		187,000		214,389

Long-term debt, net of current portion	$	2,678,370	$	3,206,931

During the nine months ended , notes totaling $187,000 were due. Subsequent to September 30, 2016, these notes were extended until December 24, 2016.

Related-Party Note payable

During the nine months ended September 30, 2016 the Company issued notes to related parties for $185,000. Also during the nine months ended September 30, 2016 $55,000 of the related party notes were paid back along with interest and fees of $599.

Note Payable to a Relative of an Executive Officer

At September 30, 2016 and December 31, 2015, the Company was obligated under the terms of a master note to an individual related to an executive officer of the Company in the amount of $189,389. The note is secured by all the assets of the Company, bears interest at 15% per annum, and requires the board of directors to retain the current management as long as the note is outstanding. The note was extended on June 30, 2016 and is now due September 30, 2018. The balance of accrued interest at September 30, 2016 and December 31, 2015 was $21,326 and $1,012, respectively. As part of the extension of the due date, the Company analyzed the note and determined that the change in due date did not qualify as a debt modification under generally accepted accounting principles and accordingly, moved the note to long-term.

Fresh Medical Laboratories, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 5 – Common Stock

Private Placement of Common Stock of the Company

Pursuant to a Private Placement Memorandum dated December 28, 2015, the Company is offering a minimum of 333,333 shares, or a maximum of 3,500,000 shares of its common stock at a purchase price of $1.50 per share, for a minimum offering amount of $500,000 and a maximum offering amount of $5,250,000. The shares are being offered to a limited number of prospective investors who qualify as “accredited investors”. The shares are being offered on a “best efforts, all-or-none” basis for the first 333,333 shares subscribed for and on a “best efforts” basis thereafter. The offering proceeds were being deposited into an escrow account until a minimum of 333,333 shares were sold for cash, at which time the proceeds were released to the Company. During the nine months ended September 30, 2016, 659,038 shares were subscribed, conditions for the minimum offering were met, and the Company received net proceeds of $882,224 from the offering.

Concurrently with the Private Placement Memorandum, the Company entered into a Placement Agent Agreement, effective December 28, 2015, that provides for compensation to a Placement Agent in connection with the offering of common stock. Pursuant to the Placement Agent Agreement, the Company will pay the Placement Agent a cash commission of ten percent of the issuance price of the common stock sold in the offering, and one share of common stock of the Company for each ten shares of the Company’s common stock sold in the offering. Pursuant to these provisions, with the release of shares described in the previous paragraph, the Company incurred commission fees to the Placement Agent of $106,334 and is obligated to issue the Placement Agent 65,905 shares of common stock. The Placement Agent will also receive an expense allowance of up to $10,000 to reimburse it for direct out-of-pocket costs related to the offering and the Escrow Agent was paid $1,000 for services in connection with the offering. Legal fees of $6,478 were also paid in connection with the offering

Common Stock Issued for Conversion of Debt

During the nine months ended September 30, 2016, certain convertible debenture holders exercised their right and converted $717,950 of principal and $67,217 of accrued interest into common stock. The Company issued 1,207,951 shares of common stock at $0.65 per share.

Common Stock Issued for Services

Periodically, the Company issues non-vested common stock to directors, officers and consultants as compensation for future services. During the nine months ended September 30, 2016, the Company recognized $121,400 in stock compensation expense related to the amortization of this deferred compensation.

In addition, during the nine months ended September 30, 2016, the Company issued 19,767 shares of common stock with a total value of $29,651 to two consultants for services rendered.

A summary of the status of the Company’s non-vested shares as of September 30, 2016 and changes during the nine months then ended, is presented below:


	Non-vested
	Shares of		Weighted
	Common		Average
	Stock		Fair Value

Balance at December 31, 2015	253,670	$	0.50
Awarded	-		-
Vested	(242,799)		0.50

Balance at September 30, 2016	10,871	$	0.50

Fresh Medical Laboratories, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

As of September 30, 2016 there was $10,871 of total unrecognized compensation cost related to the non-vested stock-based compensation arrangements awarded to directors, officers, and consultants. That cost is expected to be recognized over a weighted-average period of 0.3 years.

Total stock-based compensation expense from all sources for the three and nine months ended September 30, 2016 and 2015, including stock-based compensation for the warrant discussed below in Note 6, has been included in the condensed consolidated statements of operations as follows:


		For the Three Months Ended				For the Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015

Research and development expense	$	79,915	$	41,343	$	227,392	$	112,501
Selling, general and administrative expense		30,854		38,894		104,849		126,264

Total share-based compensation	$	110,769	$	80,237	$	332,241	$	238,765

Note 6 – Common Stock Warrants

The Company has issued warrants to purchase its common stock for payment of consulting services, in connection with the extension of a note payable, as incentives to investors, and for cash. The fair value of warrants issued for consulting services is recognized as consulting expense at the date the warrants become exercisable. The Company values non-vested warrants based on the fair value of the stock on the date of issuance and records compensation over the requisite service period which is usually the vesting period. The non-vested shares are included in the total outstanding shares recorded in the condensed consolidated financial statements. The fair value of warrants was estimated using the Black-Scholes option pricing model. The fair value of the warrant shares that vested during the nine months ended September 30, 2016 was $1.34 per share. The weighted-average assumptions used for the warrant shares that vested during the nine months ended September 30, 2016 were risk-free interest rate of 1.29%, expected volatility of 121%, expected life of 4.5 years, and expected dividend yield of zero. The fair value of the warrant shares that vested during the year ended December 31, 2015 was $0.402 per share. The weighted-average assumptions used for the warrant shares that vested during the year ended December 31, 2015 were risk-free interest rate of 1.70%, expected volatility of 71%, expected life of 5.2 years, and expected dividend yield of zero. The Company recognized $181,190 and $50,113 as share-based compensation and additional paid-in capital related to the vesting of warrant shares for the nine months ended September 30, 2016 and 2015 respectively. The Company recognized $60,905 and $21,519 as share-based compensation related to the vesting of warrant shares for the three months ended September 30, 2016 and 2015, respectively.

A summary of warrant activity for the nine months ended September 30, 2016 is presented below:


				Weighted		Aggregate
			Weighted	Average		Intrinsic
	Shares		Average	Remaining		Value of
	Under		Exercise	Contractual		Vested
	Warrants		Price	Life		Warrants

Outstanding at December 31, 2015	1,423,211	$	0.54	7.3 years	$	213,364
Issued	-		-
Exercised	-		-
Expired	-		-

Outstanding at September 30, 2016	1,423,211	$	0.54	6.6 years	$	1,055,257

Fresh Medical Laboratories, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

The intrinsic value at September 30, 2016 is calculated at $1.50 per share less the exercise price, based on the management’s latest estimate of the fair value of the shares of common stock, which is the latest price the Company issued shares of common stock for cash.

Note 7 – Commitments and Contingencies

Consulting Representation Agreement

On January 1, 2016, the Company entered into a Consulting Representation Agreement with two consultants located in the European Union. Pursuant to the Consulting Representation Agreement, the consultants have agreed to the completion of certain marketing milestones related to relationship development with key government and regulatory officials in the European Union and the introduction and marketing of the Company’s products to potential medical, clinical and hospital customers of the member states of the European Union. Under the Consulting Representation Agreement, the Company is obligated to pay the consultants $70,000 per calendar quarter for the expenses. The Consulting Representation Agreement is subject to termination by either the Company or by the consultants upon 15 days’ written notice. Additionally, as an inducement to launch the European market as market representatives without other commission receivable, the Consulting Representation Agreement provides that for a period of one year, the consultants may receive up to the value of the compensation margin (actual net revenue less all actual expense, including marketing expense) in shares of the Company’s common stock valued at $1.50 per share and paid at the earliest of termination of the Consulting Representation Agreement or December 31, 2016.

Lease Agreement –Monthly rental payments as of September 30, 2016 are $3,940 per month. If the Company exercises the option to renew the lease, the monthly rental payments will further escalate by 3% per year during the additional term.

Minimum lease commitments at September 30, 2016 for the remaining term of the lease are as follows:


Year ending September 30,
	2017	$	39,397
	Thereafter		-

	Total	$	39,397

Lease expense charged to operations related to this agreement for the nine months ended September 30, 2016 and 2015 was $34,917 and $36,907, respectively.

License Agreement – The Company has a license agreement with a party related through a shareholder and former member of the board of directors. Under the agreement, the Company has the right to the exclusive use of certain patents pending and related technology (the “technology”) in its medical devices and other products for an indefinite term. In return, the Company agreed to incur a minimum of $4,750,000 in development costs by the year 2014 to develop and market its products worldwide based on a graduated schedule and to make royalty payments based on a percentage of the aggregate worldwide net sales (as defined in the agreement) of its medical device and other products that utilize the technology. At September 30, 2016 and December 31, 2015, accrued royalties under this license agreement total $17,873, respectively.

Note 8 – Other Related Party Transactions

During the nine months ended September 30, 2016, the Company has consulting agreements in place with two of the members of its board of directors. The directors provide marketing and medical advisory services. One of the agreements was terminated during the nine months ended September 30, 2016. The remaining consulting agreement may be terminated by either the Company or by the consultant at any time and for any reason. During the nine months ended September 30, 2016, the directors were paid a total of $135,000 under these agreements.

Fresh Medical Laboratories, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 9 – Subsequent Events

Subsequent to September 30, 2016, 88,001 shares of common stock were issued for $132,002 cash as well as 8,800 shares of common stock were issued to the placement agent.

The Company evaluated all subsequent events that occurred after the balance sheet date through November 14, 2016, the date its financial statements were available to be issued, and concluded there were no additional events or transactions occurring during this period that required recognition or disclosure in the financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with the financial statements and related notes that appear elsewhere in this Form 10-Q and the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

Certain statements in this Form 10-Q constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; receipt or denial of marketing approval from the FDA and similar agencies; receipt or denial of reimbursement from government agencies and insurance companies; changes in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from customers; announcements or changes in our pricing policies or that of our competitors; unanticipated delays in the development, market acceptance or installation of our products and services; changes in government regulations; availability of management and other key personnel; availability, terms and deployment of capital; relationships with third-party equipment suppliers; and worldwide political stability and economic growth. The words "believe", "expect", "anticipate", “will”, "intend" and "plan" and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made.

Overview

Fresh Medical Laboratories, Inc. was incorporated under the laws of the State of Delaware on November 19, 2004 and does business under the trade name ProLungdx®. We are a medical device company that is developing, testing and commercializing our non-invasive lung cancer risk stratification test (the “Electro Pulmonary Nodule Scan” or “EPN Scan,”). The EPN Scan is adjunctive to Computed Tomography (“CT”), or what is commonly referred to as a “CT scan” of the chest. The EPN Scan assists in evaluating the risk associated with a CT finding in the lung that is suspicious for cancer.

As many patients at high risk of lung cancer have suspicious lung findings when evaluated by CT, clarifying the risk of the disease, or risk stratification, has the potential to reduce the cost, anxiety, and/or time associated with the inaccurate and/or delayed diagnosis of lung cancer. Risk stratification may also play a role in identifying those patients who need to modulate the extent and frequency of follow-up. On December 31, 2013, the U.S. Preventative Services Task Force recommended CT screening guidelines for lung cancer in adults aged 55 to 80 who have a 30 pack-year history and currently smoke or have quit smoking in the past 15 years. This guideline is expected to increase the number of patients with suspicious findings in the lung that may be candidates for the EPN Scan.

On May 10, 2013, the EPN Scan received the “CE” mark in Europe for its Electro Pulmonary Nodule Scanner and Probe. This marking is regulatory approval that clears the marketing and sale of the EPN Scan in the European Economic Area and European Free Trade Association Countries representing 509 million individuals and 31 member states. The new screening guidelines and Medicare coverage recently announced in the U.S. for lung cancer screening are not available in Europe.

In the United States, we have submitted an application for marketing approval under Section 510(k) from the United States Food and Drug Administration, or FDA. On February 27, 2015, we received a review letter from the FDA identifying a number of issues, concerns and weaknesses in our application, including the risk classification of the test, the study design and study analysis along with what we consider other less important questions. On July 16, 2015, we met with the FDA to clarify and refine our understanding of the issues related to our pending application. Before the FDA can grant approval of our application, we must resolve or negotiate the removal of all issues identified by the FDA and address possible issues to be identified in the future. Certain completed studies address some of the issues identified by the FDA, and we responded to the FDA regarding certain outstanding issues by August 27, 2015. As of August 27, 2015, the Company, in consultation with the FDA, determined that the remaining issues would require additional time for submission. Consequently, the device would undergo an automatic withdrawal followed by a re-application once the requested data was available for submission. The Company is now preparing a response.

From inception to date, we have generated limited revenues. During the year ended December 31, 2014, we commenced selling the EPN Scan to customers in the European Union.

We plan to continue the development and deployment of medical devices and procedures specializing in the immediate, non-invasive evaluation of indeterminate masses in the lung seen in CT and radiography. We anticipate the need to fund expansion and market growth by raising capital over the next two years. The amount of capital needed could change based on the opportunities available to us and the ability to expand our markets.

Results of Operations

The following discussion is included to describe our consolidated financial position and results of operations. The consolidated financial statements and notes thereto contain detailed information that should be referred to in conjunction with this discussion.

Three Months Ended September 30, 2016 compared to the Three Months Ended September 30, 2015

Revenues and Cost of Revenue. During the three months ended September 30, 2016, we had no revenues as compared to $10,450 of revenue for the three months ended September 30, 2015. The 2015 revenue was a result of providing consulting services to our licensee in China. These consulting services were not needed during 2016. For the three months ended September 30, 2016, there was no cost of revenues. For the three months ended September 30, 2015, cost of revenues includes the cost of direct materials and labor for the assembly of the units, other indirect costs related to the purchase and assembly of inventory, plus the accrual of royalties under our technology license agreement.

Operating Expenses. Total operating expenses for selling, general and administrative expense and for research and development expense for the three months ended September 30, 2016 were $601,981, compared to the total operating expenses for the three months ended September 30, 2015, of $788,069, representing a decrease of $186,088. This decrease was due to 1) a decrease of $84,009 in travel costs related to our decreased regulatory and business development activities; 2) a decrease of $79,291 for professional fees also related to our decreased regulatory and business development activities; and 3) a net decrease of $40,271 in remaining operating expenses also related generally to our decreased operational activities. These decreased expenses were offset by an increase of $17,483 for payroll expenses, principally for consulting services related to our increased clinical and production activities. Operating expenses have been classified by management as either selling, general and administrative expense or as research and development expense based on an assignment of certain expenses directly to these classifications or based on management’s allocation of certain expenses between these classifications.

Other income/(expense). Other income (expense) amounted to net expense of $65,526 for the three months ended September 30, 2016, as compared to net expense of $81,335 for the three months ended September 30, 2015. Other income (expense) for the three months ended September 30, 2016 consists of interest expense of $65,526. Other income (expense) for the three months ended September 30, 2015 consists of interest expense of $79,004 and a foreign currency exchange loss of $2,331.

The decrease in interest expense during the three months ended September 30, 2016 principally relates to several Convertible Debentures being converted during the period. Otherwise, interest expense represents interest accrued on the remaining Convertible Debentures as well as notes to a former director and to a relative of an executive officer.

Accounts receivable for sales of the EPN Scan units and test kits in Europe are denominated in Euros and Swiss Francs, and translated into U.S. Dollars at the date of each sale and at each balance sheet date. The foreign currency exchange losses of $2,331 for the three months ended September 30, 2015 are the result of the changes in the exchange rates of Euros and Swiss Francs during the three-month period ended on September 30, 2015.

Nine months Ended September 30, 2016 compared to the Nine months Ended September 30, 2015

Revenues and Cost of Revenue. During the nine months ended September 30, 2016, we had no revenues as compared to $19,450 of revenue for the nine months ended September 30, 2015. The 2015 revenue was a result of providing consulting services to our licensee in China as well as selling two EPN scan units to our licensee in China pursuant to the pricing provisions of our license. The consulting services were not needed and no EPN scan units were sold during 2016. For the nine months ended September 30, 2016, cost of revenues of $10,193 represented old inventory that was written off for accounting purposes. For the nine months ended September 30, 2015, cost of revenues of $15,563 includes the cost of direct materials and labor for the assembly of the units, other indirect costs related to the purchase and assembly of inventory, plus the accrual of royalties under our technology license agreement.

Operating Expenses. Total operating expenses for selling, general and administrative expense and for research and development expense for the nine months ended September 30, 2016 were $1,871,683, compared to the total operating expenses for the nine months ended September 30, 2015 of $1,714,526, representing an increase of $157,157. This increase was due to 1) an increase of $78,863 in professional fees related to our clinical, regulatory, and business development activities; 2) an increase in non-cash stock-based compensation of $63,825 that results based on the vesting arrangements of common stock and warrants that have been issued for services; 3) an increase of $100,357 in payroll expenses, and 4) a net increase of $35,654 in remaining operating expenses also related generally to our increased operational activities. These increased expenses were offset by 1) a decrease of $73,727 for traveling expense, principally for consulting services related to our decreased clinical, regulatory, and business development activities; and 2) a decrease of $47,815 for the provision for doubtful accounts for accounts receivable based on management’s estimates of the collectability of accounts receivable at each reporting date. Operating expenses have been classified by management as either selling, general and administrative expense or as research and development expense based on an assignment of certain expenses directly to these classifications or based on management’s allocation of certain expenses between these classifications.

Other income/(expense). Other income (expense) amounted to net expense of $204,282 for the nine months ended September 30, 2016, as compared to net expense of $215,699 for the nine months ended September 30, 2015. Other income (expense) for the nine months ended September 30, 2016 consists of interest expense of $204,282. Other income (expense) for the nine months ended September 30, 2015 consists of interest expense of $193,412 and a foreign currency exchange loss of $22,287. The increase in interest expense during the nine months ended September 30, 2016 principally relates to several new Convertible Debentures accruing interest.

Accounts receivable for sales of the EPN Scan units and test kits in Europe are denominated in Euros and Swiss Francs, and translated into U.S. Dollars at the date of each sale and at each balance sheet date. The foreign currency exchange losses of $22,287 for the nine months ended September 30, 2015 are the result of the changes in the exchange rates of Euros and Swiss Francs during the nine-month period ended on September 30, 2015.

Liquidity and Capital Resources

The following is a summary of our key liquidity measures at September 30, 2016 and 2015:


		September 30,
		2016		2015

Cash	$	41,236	$	976,250

Current assets	$	79,966	$	1,246,567
Current liabilities		(756,051)		(978,853)

Working capital (deficit)	$	(676,085)	$	267,714

In June 2014, the FDA informed us that 510(k) clearance would not be available to the Company for its EPN Scan device and indicated that a 510(k) de novo petition may be an appropriate pathway to approval due to the novel technology and indication used in the device based upon section 513(a)(1) of the Food, Drug and Cosmetic Act. The enhanced 510(k) de novo petition was prepared and submitted to the FDA for review in 2014. On February 27, 2015, we received a review letter from the FDA identifying a number of issues, concerns and weaknesses in our application, including the risk classification of the test, the study design and study analysis along with what we consider other less important questions. Before the FDA can grant approval of our application, we must resolve or negotiate the removal of all issues identified by the FDA and address possible issues to be identified in the future. Certain completed studies address some of the issues identified by the FDA, and we have developed a plan to address the remaining issues as soon as practicable. The Company has established a budget and is seeking the funding required to satisfy the additional request. The nature and scale of any additional requests, if any, are unknown, and will not be known until the FDA makes a definitive response to a new 510(k) de novo petition pending that we will file when we believe that we have addressed the FDA’s comments.

If we obtain FDA clearance to market in the United States of America, we plan to convert U.S. hospitals with existing investigational placements of our diagnostic to commercial installations selling our EPN Scan. The funds required for the United States market launch are estimated to be approximately $4.0 million. Funds for this purpose, and for ordinary operations, may be obtained in part through the sales of our products and services in Europe but primarily from the sale of debt and equity securities. During the fourth quarter of 2015, we commenced a private placement offering with a minimum of 333,333 shares or a maximum of 3,500,000 shares of common stock at a purchase price of $1.50 per share. The shares are being offered on a “best efforts, all-or-none” basis for the first 333,333 shares subscribed. During the nine months ended September 30, 2016, conditions for the minimum offering were met and the company issued 659,038 shares, and received net proceeds of $882,224 from the offering. We have no existing commitment to provide working capital, and given our early stage of development, we may be unable to raise sufficient capital when needed and may be required to pay a high price for capital.

Our future capital requirements and adequacy of available funds will depend on many factors including:

our ability to obtain regulatory approval in markets outside of Europe;

our ability to successfully commercialize our EPN Scan, EPN Scanner and related products and the market acceptance of these products;

the pace of our orders, if any, and the pricing and payment terms of those orders;

our ability to establish and maintain collaborative arrangements with corporate partners for the development and commercialization of certain product opportunities;

the cost of manufacturing and production scale-up;

our financial results;

the cost and availability of capital generally; and

the occurrence of unexpected adverse expenses or events.

Long-Term Debt

Since our inception, the principal source of our financing has come from the issuance of equity securities and from debt financing. As of September 30, 2016, our outstanding debt financing includes the following borrowing arrangements.

Convertible Debentures

As of April 30, 2015, we had completed an offering and issued Convertible Debentures totaling $2,000,000. The Convertible Debentures bear interest at the rate 8% per annum commencing on the issuance date in April 2015. Principal and accrued interest are due on the maturity date, which is May 1, 2018. The holder of the Convertible Debenture is entitled, at its option, to convert all or any portion of the outstanding principal of the Convertible Debenture into shares of our common stock at a conversion price of $0.65 per share. Interest accruing from the date of issuance to the conversion date shall be paid on the maturity date. During the nine months ended September 30, 2016, $717,950 of these debentures along with $67,217 of accrued interest were converted to common stock.

Note Payable to a Relative of an Executive Officer

At September 30, 2016, we were obligated under the terms of a master note agreement to an individual related to an executive officer of the Company in the amount of $189,389. The note is secured by all of our assets and bears interest at 15% per annum and is due June 30, 2018. The balance of accrued interest on this note at September 30, 2016 was $22,337.

Cash provided by (used in) operating, investing and financing activities for the nine months ended September 30, 2016 and 2015 is as follows:


		September 30,
		2016		2015

Operating activities	$	(1,454,514)	$	(1,703,599)
Investing activities		-		(62,619)
Financing activities		1,044,224		2,738,424

Net increase (decrease) in cash	$	(410,290)	$	972,206

Operating Activities

For the nine months ended September 30, 2016, the differences between our net loss and net cash used in operating activities were due to net non-cash charges totaling $367,323 included in our net loss for stock-based compensation, depreciation, stock issued for services, and loss on inventory obsolescence. For the nine months ended September 30, 2015, the differences between our net loss and net cash used in operating activities were due to net non-cash charges totaling $293,347 included in our net loss for stock-based compensation, depreciation, and provision for doubtful accounts.

Investing Activities

During the nine months ended September 30, 2016, the Company had no activities classified as investing activities. Net cash used in investing activities during the nine months ended September 30, 2015 was $62,619, and was for the purchase of property and equipment. We currently estimate the amount of capital expenditures for the year ending December 31, 2016 to be approximately $150,000.

Financing Activities

During the nine months ended September 30, 2016, cash flows from financing activities totaled $1,044,224, related to 1) proceeds of $882,224 from the issuance of 659,038 shares of common stock, 2) proceeds of $185,000 from related party debt, 3) proceeds of $32,000 from debt, and 4) repayments of $55,000 of principal on related party debt.

During the nine months ended September 30, 2016, notes totaling $187,000 were due. These notes were extended until December 24, 2016.

Critical Accounting Policies and Estimates

Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. The allowance for doubtful accounts is particularly susceptible to change in the near term.

Revenue Recognition – Revenue is recognized by the Company when a binding sales or service agreement exists between the parties, services have been rendered, the price for the services is fixed or determinable, collection is reasonably assured, and the Company has no significant obligations remaining with respect to the arrangement.

Trade Receivables and Credit Policies – Accounts receivable are recorded at the invoiced amount, with foreign currencies reflected in U.S. dollars (based on the exchange rate on the date of sale and adjusted to current exchange rates at the end of each reporting period), and do not bear interest. The Company uses an allowance for doubtful accounts to reflect the Company’s best estimate of the amount of probable credit losses in accounts receivable. Account balances will be charged off against the allowance when the account receivable is considered uncollectible. The allowance for doubtful accounts is an estimate that is particularly susceptible to change in the near term.

Inventory – Inventory is valued at the lower of cost or market value, with cost determined based on the first-in-first-out method. Management evaluates inventory for obsolescence based on expectations about future demand and marketability of products, and if necessary, reduces inventory to the lower of cost or market through the use of on inventory valuation account for obsolescence. The estimated cost of inventory not expected to be converted to cash within one year is reflected as “Inventory, noncurrent” in the consolidated balance sheet.

Long-lived Assets – Long-lived assets, including property and equipment, and intangible assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. When such events occur, we compare the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group to the carrying amount of the long-lived asset or asset group. If this comparison indicates that there is an impairment, the amount of the impairment is calculated based on fair value.

Stock-based Compensation – The Company measures the cost of employee and consulting services received in exchange for an award of equity instruments based on the grant-date fair value of the award. The awards issued are valued using a fair value-based measurement method. The resulting cost is recognized over the period during which an employee or consultant is required to provide services in exchange for the award, usually the vesting period.

Emerging Growth Company – We are an “emerging growth company” under the federal securities laws and will be subject to reduced public company reporting requirements. In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. Although we have not delayed the adoption of any accounting standards, we may choose to take advantage of the extended transition period for complying with new or revised accounting standards in the future.

Off Balance Sheet Arrangements

The Company has not had any off balance sheet arrangements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company and, as a result, are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of September 30, 2016. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure; provided, however, as of September 30, 2016, the following material weakness in our internal controls and procedures existed:

The Company did not maintain effective entity-level internal controls as defined by the framework issued by COSO. Specifically, the Company did not effectively segregate certain accounting duties due to the small size of the Company’s accounting staff, and did not maintain a sufficient number of adequately-trained personnel necessary to anticipate and identify risks critical to financial reporting.

In order to mitigate these material weaknesses to the fullest extent possible, all financial reports are reviewed by the Chief Executive Officer/Chief Financial Officer. In addition, we engage a third-party accounting firm to provide additional expertise in accounting for non-routine or complex transactions. Furthermore, regular meetings are held with the Board of Directors. If at any time we determine a new control can be implemented to mitigate these risks at a reasonable cost, it is implemented as soon as possible.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred in the nine months ended September 30, 2016 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II--OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There have occurred no events requiring disclosure under this item.

ITEM 1A. RISK FACTORS

We are a smaller reporting company and, as a result, are not required to provide the information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

The offer and sale of such shares of common stock is being effected in reliance upon the exemptions for sales of securities not involving a public offering, as set forth in Section 4(2) of the Securities Act and as set forth in Rule 506(b) under the Securities Act, based upon the following: (a) each investor has confirmed to us that the investor was an “accredited investor,” as defined in Rule 501 promulgated under the Securities Act and had such background, education and experience in financial and business matters as to be able to evaluate the merits and risks of an investment in the securities; (b) there has been no public offering or general solicitation with respect to each offering; (c) the investors were provided with certain disclosure materials and all other information requested with respect to our company; (d) the investors acknowledged that all securities being purchased were “restricted securities” for purposes of the Securities Act, and agreed to transfer such securities only in a transaction registered under the Securities Act or exempt from registration under the Securities Act; and (e) a legend was placed on the certificates representing each such security stating that it was restricted and could only be transferred if subsequently registered under the Securities Act or transferred in a transaction exempt from registration under the Securities Act; and (f) a Form D has been filed with respect to the offering.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS


Exhibit Number	Description
3.1	Second Amended and Restated Certificate of Incorporation⁽²⁾
3.2	By-Laws⁽¹⁾
31.1	Certification Pursuant to Rule 13a-14 and 15d-14 under the Securities Exchange Act of 1934, as Amended*
31.2	Certification Pursuant to Rule 13a-14 and 15d-14 under the Securities Exchange Act of 1934, as Amended*
32.1	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

101 INS	XBRL Instance Document*
101 SCH	XBRL Schema Document*
101 CAL	XBRL Calculation Linkbase Document*
101 LAB	XBRL Labels Linkbase Document*
101 PRE	XBRL Presentation Linkbase Document*
101 DEF	XBRL Definition Linkbase Document*

* Filed herewith

(1)

Incorporated by reference with Form 10 filed February 10, 2012, File No. 12750426.

(2)

Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on December 9, 2014.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


			FRESH MEDICAL LABORATORIES, Inc.

	November 14, 2016		By: /s/ Steven C. Eror
	Date		Steven C. Eror,
			Chief Executive Officer and President (Principal Executive Officer)


	November 14, 2016		By: /s/ Steven C. Eror
	Date		Steven C. Eror,
			Chief Financial Officer (Principal Financial Officer)

EX-31.1 2 f10q093016_ex31z1.htm EXHIBIT 31.1 SECTION 302 CERTIFICATION Exhibit 31.1 Section 302 Certification

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven C. Eror, certify that:

I have reviewed this quarterly report on Form 10-Q of Fresh Medical Laboratories, Inc. for the nine months ended September 30, 2016.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	November 14, 2016	/s/ Steven C. Eror
		Steven C. Eror, Chief Executive Officer (Principal Executive Officer)

EX-31.2 3 f10q093016_ex31z2.htm EXHIBIT 31.2 SECTION 302 CERTIFICATION Exhibit 31.2 Section 302 Certification

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven C. Eror, certify that:

I have reviewed this quarterly report on Form 10-Q of Fresh Medical Laboratories, Inc. for the nine months ended September 30, 2016.

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	November 14, 2016	/s/ Steven C. Eror
		Steven C. Eror, Chief Financial Officer (Principal Financial Officer)

EX-32.1 4 f10q093016_ex32z1.htm EXHIBIT 32.1 SECTION 906 CERTIFICATION Exhibit 32.1 Section 906 Certification

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Fresh Medical Laboratories, Inc. (the “Company”) for the nine months ended September 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), I, Steven C. Eror, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated:		November 14, 2016	/s/ Steven C. Eror
			Steven C. Eror
			Chief Executive Officer (Principal Executive Officer)

EX-32.2 5 f10q093016_ex32z2.htm EXHIBIT 32.2 SECTION 906 CERTIFICATION Exhibit 32.2 Section 906 Certification

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Fresh Medical Laboratories, Inc. (the “Company”) for the nine months ended September 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), I, Steven C. Eror, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:		November 14, 2016	/s/ Steven C. Eror
			Steven C. Eror
			Chief Financial Officer (Principal Financial Officer)

EX-101.CAL 6 fres-20160930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 fres-20160930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.INS 8 fres-20160930.xml XBRL INSTANCE DOCUMENT

41236

451526

35174

3556

30520

79966

517220

358908

206722

88823

106541

168129

175300

695826

1005783

328155

97849

240896

138683

155000

25000

32000

189389

756051

450921

189389

1206931

1282050

2000000

2678370

3206931

3434421

3657852

23479

21525

12634261

10636583

-15396335

-13310177

-2738595

-2652069

695826

1005783

0 194467

0.001

10000000

0.001

40000000

23477787

21525126

23477787

21525126

10450

19450

10450

19450

7763

10193

15563

2687

-10193

3887

241809

389851

806052

877552

360172

398218

1065631

836974

601981

788069

1871683

1714526

-601981

-785382

-1881876

-1710639

65526

79004

204282

193412

-2331

-22287

65526

81335

204282

215699

-667507

-866717

-2086158

-1926338

-0.03

-0.04

-0.09

-0.1

22964764

20448611

22349903

20013387

-2086158

-1926338

24889

6767

302590

238765

10193

29651

47815

50711

-162379

1092

26964

5384

230306

-6235

169430

-121560

-1454514

-1703599

62619

-62619

882224

807960

2000000

-40000

29536

32000

185000

55000

1044224

2738424

-410290

972206

451526

4044

41236

976250

48744

309658

785167 61935 66

Note 1 Organization and Summary of Significant Accounting Policies   Organization Fresh Medical Laboratories, Inc. (the Company) is a Delaware corporation that was incorporated on November 22, 2004 and is doing business as ProLungdx. The Companys headquarters are located in Salt Lake City, Utah. The Companys business is the development and deployment of medical devices and procedures specializing in the immediate, non-invasive evaluation of indeterminate lung masses suspicious for cancer as seen in CT and radiography. The Companys principal activities have consisted of research and development, developing markets for its products, securing strategic alliances and obtaining financing.  The Company has developed and tested, and is commercializing its non-invasive lung cancer risk stratification test, the Electro Pulmonary Nodule Scan (EPN Scan).  In April 2013, the Company entered into an agreement to license this technology to a distributor for the China market.  In May 2013, the Company received the CE mark in Europe permitting the marketing of the EPN Scan in the European Union and certain other countries.  During the year ended December 31, 2014, the Company commenced selling the EPN Scan to customers in the European Union.  In the United States, the Company has submitted its application for marketing approval to the United States Food and Drug Administration but has since withdrawn such application with the intent of re-submitting it once certain tests are complete.   Principles of Consolidation During the year ended December 31, 2012, the Company formed a wholly-owned subsidiary, Hilltop Acquisition Corporation, Inc., which has had no activity since its inception and is included in the accompanying condensed consolidated financial statements from the date of its formation.   Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has commenced selling the EPN Scan in Europe and to a licensee for China, but has generated minimal revenues thus far from operations. Therefore, the Company has not yet achieved its planned level of operations. The Company has incurred substantial and recurring losses to date from operations, and has used cash in its operating activities during the nine months ended September 30, 2016 and 2015. Additionally, the Company had a stockholders deficit as of September 30, 2016. These conditions raise substantial doubt about the Companys ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result relating to the recoverability and classification of the asset carrying amounts or the amount and classification of liabilities that might result from the outcome of this risk and uncertainty.   The ability of the Company to continue as a going concern is dependent on the Company successfully developing products that can be sold profitably, and in the near term successfully generating cash through financing and operating activities. Managements plans include issuing equity or debt securities to fund capital requirements and ongoing operations. Additionally, the Company commenced selling the EPN Scan during the year ended December 31, 2014. However, there can be no assurance the Company will be successful in these efforts.   Basis of Presentation The accompanying condensed consolidated financial statements have been prepared by management in accordance with rules and regulations promulgated by the U.S. Securities and Exchange Commission and therefore certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments necessary for them to be presented fairly, with those adjustments consisting only of normal recurring adjustments. These interim financial statements should be read in conjunction with the Companys annual consolidated financial statements included in the Companys annual report on Form 10-K for the year ended December 31, 2015. The results of operations for the nine months ended September 30, 2016 may not be indicative of the results to be expected for the year ending December 31, 2016.   Basic and Diluted Loss Per Share The Company computes basic loss per share by dividing net loss by the weighted-average number of common shares outstanding during the period. The Company computes diluted loss per share by dividing net loss by the sum of the weighted-average number of common shares outstanding and the weighted-average dilutive common share equivalents outstanding.  The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect.  As of September 30, 2016 and 2015, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:       <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="236" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:177pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> For the Three and Nine Months Ended</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="236" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:177pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Warrants to purchase shares</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Non-vested shares</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 10,871</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 505,634</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible debentures</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,204,068</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 3,076,923</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible notes</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,641,692</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr></table></div>   Recent Accounting Pronouncements   In February 2016, the Financial Accounting Standards Board (the FASB) issued Accounting Standards Update (ASU) No. 2016-02, Leases (ASU 2016-02). ASU 2016-02 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. ASU 2016-02 will be effective for the Companys fiscal year beginning January 1, 2019 on a modified retrospective basis and earlier adoption is permitted. Management is currently evaluating the impact of the pending adoption of ASU 2016-02 on the Companys consolidated financial statements.   In March 2016, the FASB issued ASU 2016-09, Stock Compensation (ASU 2016-09), which simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows.  ASU 2016-09 will be effective for annual periods beginning after December 15, 2016 and interim periods within those annual periods.  It is not anticipated that this update will have a material effect on the Companys consolidated financial statements.

Note 2 Inventory   Inventory valued at $10,193 was written off during the nine months ended September 30, 2016 due to obsolescence and is reported as cost of revenues in the accompanying statement of operations. Inventory consists of the following:   <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="434" style='width:325.2pt;border-collapse:collapse'> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> September 30,</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> December 31,</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2016</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2015</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Raw materials</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 93,792</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 76,925</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Work in progress</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 49,146</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 58,376</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Finished goods</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 251,144</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 106,595</td></tr> <tr style='height:3.5pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'>   Total inventory </td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 394,082</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 241,896</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Less carrying value of inventory not deemed to be a current asset </td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 358,908</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 206,722</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'>   Inventory, included in current assets </td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 35,174</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 35,174</td></tr></table></div>

Note 3 Accrued Liabilities   Accrued liabilities consisted of the following:   <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="431" style='width:323pt;border-collapse:collapse'> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> September 30,</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> December 31,</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2016</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2015</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Accrued interest</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 203,798</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 115,627</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Accrued royalties</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 17,873</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 17,873</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Accrued payroll and payroll taxes</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 19,225</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 5,183</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Total accrued liabilities</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 240,896</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 138,683</td></tr></table></div>

Note 4 Short and Long-term Debt   Short and Long-term debt is summarized as follows:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr align="left"> <td width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> December 31,</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018; $717,950 was converted to stock during the nine months ended September 30, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,282,050</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,000,000</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible notes payable; unsecured; interest at 8.00% per annum; due November 6, 2020</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,206,931</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,206,931</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Note payable secured by all the assets of the Company; interest at 15.00% per annum; due June 30, 2018</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 189,389</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 189,389</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Note payable; interest at 10.00% per annum; due December 24, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 32,000</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Short term related party bridge loans; unsecured; interest at 8-10% per annum; due December 24, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 155,000</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Related-party note payable; interest at 8%; due August 31, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 25,000</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Total long-term debt</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,865,370</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 3,421,320</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Less:  current portion</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 187,000</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 214,389</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Long-term debt, net of current portion</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,678,370</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 3,206,931</td></tr></table></div>   During the nine months ended , notes totaling $187,000 were due. Subsequent to September 30, 2016. these notes were extended until December 24, 2016.   Related-Party Note payable   During the nine months ended September 30, 2016 the Company issued notes to related parties for $185,000. Also during the nine months ended September 30, 2016 $55,000 of the related party notes were paid back along with interest and fees of $599.   Note Payable to a Relative of an Executive Officer   At September 30, 2016 and December 31, 2015, the Company was obligated under the terms of a master note to an individual related to an executive officer of the Company in the amount of $189,389. The note is secured by all the assets of the Company, bears interest at 15% per annum, and requires the board of directors to retain the current management as long as the note is outstanding. The note was extended on June 30, 2016 and is now due September 30, 2018. The balance of accrued interest at September 30, 2016 and December 31, 2015 was $21,326 and $1,012, respectively.  As part of the extension of the due date, the Company analyzed the note and determined that the change in due date did not qualify as a debt modification under generally accepted accounting principles and accordingly, moved the note to long-term.

Note 5 Common Stock   Private Placement of Common Stock of the Company   Pursuant to a Private Placement Memorandum dated December 28, 2015, the Company is offering a minimum of 333,333 shares, or a maximum of 3,500,000 shares of its common stock at a purchase price of $1.50 per share, for a minimum offering amount of $500,000 and a maximum offering amount of $5,250,000.  The shares are being offered to a limited number of prospective investors who qualify as accredited investors.  The shares are being offered on a best efforts, all-or-none basis for the first 333,333 shares subscribed for and on a best efforts basis thereafter.  The offering proceeds were being deposited into an escrow account until a minimum of 333,333 shares were sold for cash, at which time the proceeds were released to the Company.  During the nine months ended September 30, 2016, 659,038 shares were subscribed, conditions for the minimum offering were met, and the Company received net proceeds of $882,224 from the offering.       Concurrently with the Private Placement Memorandum, the Company entered into a Placement Agent Agreement, effective December 28, 2015, that provides for compensation to a Placement Agent in connection with the offering of common stock.  Pursuant to the Placement Agent Agreement, the Company will pay the Placement Agent a cash commission of ten percent of the issuance price of the common stock sold in the offering, and one share of common stock of the Company for each ten shares of the Companys common stock sold in the offering.  Pursuant to these provisions, with the release of shares described in the previous paragraph, the Company incurred commission fees to the Placement Agent of $106,334 and is obligated to issue the Placement Agent 65,905 shares of common stock.  The Placement Agent will also receive an expense allowance of up to $10,000 to reimburse it for direct out-of-pocket costs related to the offering and the Escrow Agent was paid $1,000 for services in connection with the offering. Legal fees of $6,478 were also paid in connection with the offering   Common Stock Issued for Conversion of Debt   During the nine months ended September 30, 2016, certain convertible debenture holders exercised their right and converted $717,950 of principal and $67,217 of accrued interest into common stock.  The Company issued 1,207,951 shares of common stock at $0.65 per share.   Common Stock Issued for Services   Periodically, the Company issues non-vested common stock to directors, officers and consultants as compensation for future services. During the nine months ended September 30, 2016, the Company recognized $121,400 in stock compensation expense related to the amortization of this deferred compensation.   In addition, during the nine months ended September 30, 2016, the Company issued 19,767 shares of common stock with a total value of $29,651 to two consultants for services rendered.   The Company recognized stock-based compensation related to the shares issued to directors, officers and consultants for the nine months ended September 30, 2016 and 2015 of $332,241 and $238,765, respectively.   A summary of the status of the Companys non-vested shares as of September 30, 2016 and changes during the nine months then ended, is presented below:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr align="left"> <td width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Non-vested</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Shares of</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Weighted</td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Common</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Average</td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Stock</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Fair Value</td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Balance at December 31, 2015</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 253,670</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.50</td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Awarded</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Vested</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> (242,799)</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.50</td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Balance at September 30, 2016</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 10,871</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.50</td></tr></table></div>     As of September 30, 2016 there was $10,871 of total unrecognized compensation cost related to the non-vested stock-based compensation arrangements awarded to directors, officers, and consultants. That cost is expected to be recognized over a weighted-average period of 0.3 years.     Total stock-based compensation expense from all sources for the three and nine months ended September 30, 2016 and 2015, including stock-based compensation for the warrant discussed below in Note 6, has been included in the condensed consolidated statements of operations as follows:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr align="left"> <td width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="186" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:139.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> For the Three Months Ended</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="183" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:137.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> For the Nine Months Ended</td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="186" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:139.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="183" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:137.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Research and development expense</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 79,915</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 41,343</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 227,392</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 112,501</td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Selling, general and administrative expense</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 30,854</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 38,894</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 104,849</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 126,264</td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Total share-based compensation</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 110,769</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 80,237</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 332,241</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 238,765</td></tr></table></div>

Note 6 Common Stock Warrants   The Company has issued warrants to purchase its common stock for payment of consulting services, in connection with the extension of a note payable, as incentives to investors, and for cash. The fair value of warrants issued for consulting services is recognized as consulting expense at the date the warrants become exercisable. The Company values non-vested warrants based on the fair value of the stock on the date of issuance and records compensation over the requisite service period which is usually the vesting period. The non-vested shares are included in the total outstanding shares recorded in the condensed consolidated financial statements. The fair value of warrants was estimated using the Black-Scholes option pricing model.  The fair value of the warrant shares that vested during the nine months ended September 30, 2016 was $1.34 per share. The weighted-average assumptions used for the warrant shares that vested during the nine months ended September 30, 2016 were risk-free interest rate of 1.29%, expected volatility of 121%, expected life of 4.5 years, and expected dividend yield of zero. The fair value of the warrant shares that vested during the year ended December 31, 2015 was $0.402 per share.  The weighted-average assumptions used for the warrant shares that vested during the year ended December 31, 2015 were risk-free interest rate of 1.70%, expected volatility of 71%, expected life of 5.2 years, and expected dividend yield of zero. The Company recognized $181,190 and $50,113 as share-based compensation and additional paid-in capital related to the vesting of warrant shares for the nine months ended September 30, 2016 and 2015 respectively.  The Company recognized $60,905 and $21,519 as share-based compensation related to the vesting of warrant shares for the three months ended September 30, 2016 and 2015, respectively.   A summary of warrant activity for the nine months ended September 30, 2016 is presented below:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Weighted</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Aggregate</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Weighted</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Average</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Intrinsic</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Shares</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Average</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Remaining</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Value of</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Under</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Exercise</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Contractual</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Vested</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Warrants</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Price</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Life</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Warrants</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Outstanding at December 31, 2015</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.54</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 7.3 years</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 213,364</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Issued</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Exercised</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Expired</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Outstanding at September 30, 2016</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.54</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 6.6 years</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,055,257</td></tr></table></div>       The intrinsic value at September 30, 2016 is calculated at $1.50 per share less the exercise price, based on the managements latest estimate of the fair value of the shares of common stock, which is the latest price the Company issued shares of common stock for cash.

Note 7 Commitments and Contingencies   Consulting Representation Agreement   On January 1, 2016, the Company entered into a Consulting Representation Agreement with two consultants located in the European Union.  Pursuant to the Consulting Representation Agreement, the consultants have agreed to the completion of certain marketing milestones related to relationship development with key government and regulatory officials in the European Union and the introduction and marketing of the Companys products to potential medical, clinical and hospital customers of the member states of the European Union.  Under the Consulting Representation Agreement, the Company is obligated to pay the consultants $70,000 per calendar quarter for the expenses.   The Consulting Representation Agreement is subject to termination by either the Company or by the consultants upon 15 days written notice.  Additionally, as an inducement to launch the European market as market representatives without other commission receivable, the Consulting Representation Agreement provides that for a period of one year, the consultants may receive up to the value of the compensation margin (actual net revenue less all actual expense, including marketing expense) in shares of the Companys common stock valued at $1.50 per share and paid at the earliest of termination of the Consulting Representation Agreement or December 31, 2016.   Lease Agreement Monthly rental payments as of September 30, 2016 are $3,940 per month.  If the Company exercises the option to renew the lease, the monthly rental payments will further escalate by 3% per year during the additional term.    Minimum lease commitments at September 30, 2016 for the remaining term of the lease are as follows:   <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="299" style='width:224.3pt;border-collapse:collapse'> <tr style='height:7.2pt'> <td valign="bottom" width="186" colspan="2" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Year ending September 30,</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2017</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 39,397</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Thereafter</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> -</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Total</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 39,397</td></tr></table></div>   Lease expense charged to operations related to this agreement for the nine months ended September 30, 2016 and 2015 was $34,917 and $36,907, respectively.   License Agreement The Company has a license agreement with a party related through a shareholder and former member of the board of directors. Under the agreement, the Company has the right to the exclusive use of certain patents pending and related technology (the technology) in its medical devices and other products for an indefinite term. In return, the Company agreed to incur a minimum of $4,750,000 in development costs by the year 2014 to develop and market its products worldwide based on a graduated schedule and to make royalty payments based on a percentage of the aggregate worldwide net sales (as defined in the agreement) of its medical device and other products that utilize the technology.  At September 30, 2016 and December 31, 2015, accrued royalties under this license agreement total $17,873, respectively.

Note 8 Other Related Party Transactions   During the nine months ended September 30, 2016, the Company has consulting agreements in place with two of the members of its board of directors.  The directors provide marketing and medical advisory services. One of the agreements was terminated during the nine months ended September 30, 2016. The remaining consulting agreement may be terminated by either the Company or by the consultant at any time and for any reason. During the nine months ended September 30, 2016, the directors were paid a total of $135,000 under these agreements.

Note 9 Subsequent Events   Subsequent to September 30, 2016, 88,001 shares of common stock were issued for $132,002 cash as well as 8,800 shares of common stock were issued to the placement agent.   The Company evaluated all subsequent events that occurred after the balance sheet date through November 14, 2016, the date its financial statements were available to be issued, and concluded there were no additional events or transactions occurring during this period that required recognition or disclosure in the financial statements.

Organization Fresh Medical Laboratories, Inc. (the Company) is a Delaware corporation that was incorporated on November 22, 2004 and is doing business as ProLungdx. The Companys headquarters are located in Salt Lake City, Utah. The Companys business is the development and deployment of medical devices and procedures specializing in the immediate, non-invasive evaluation of indeterminate lung masses suspicious for cancer as seen in CT and radiography. The Companys principal activities have consisted of research and development, developing markets for its products, securing strategic alliances and obtaining financing.  The Company has developed and tested, and is commercializing its non-invasive lung cancer risk stratification test, the Electro Pulmonary Nodule Scan (EPN Scan).  In April 2013, the Company entered into an agreement to license this technology to a distributor for the China market.  In May 2013, the Company received the CE mark in Europe permitting the marketing of the EPN Scan in the European Union and certain other countries.  During the year ended December 31, 2014, the Company commenced selling the EPN Scan to customers in the European Union.  In the United States, the Company has submitted its application for marketing approval to the United States Food and Drug Administration but has since withdrawn such application with the intent of re-submitting it once certain tests are complete.

Principles of Consolidation During the year ended December 31, 2012, the Company formed a wholly-owned subsidiary, Hilltop Acquisition Corporation, Inc., which has had no activity since its inception and is included in the accompanying condensed consolidated financial statements from the date of its formation.

Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has commenced selling the EPN Scan in Europe and to a licensee for China, but has generated minimal revenues thus far from operations. Therefore, the Company has not yet achieved its planned level of operations. The Company has incurred substantial and recurring losses to date from operations, and has used cash in its operating activities during the nine months ended September 30, 2016 and 2015. Additionally, the Company had a stockholders deficit as of September 30, 2016. These conditions raise substantial doubt about the Companys ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result relating to the recoverability and classification of the asset carrying amounts or the amount and classification of liabilities that might result from the outcome of this risk and uncertainty.   The ability of the Company to continue as a going concern is dependent on the Company successfully developing products that can be sold profitably, and in the near term successfully generating cash through financing and operating activities. Managements plans include issuing equity or debt securities to fund capital requirements and ongoing operations. Additionally, the Company commenced selling the EPN Scan during the year ended December 31, 2014. However, there can be no assurance the Company will be successful in these efforts.

Basis of Presentation The accompanying condensed consolidated financial statements have been prepared by management in accordance with rules and regulations promulgated by the U.S. Securities and Exchange Commission and therefore certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments necessary for them to be presented fairly, with those adjustments consisting only of normal recurring adjustments. These interim financial statements should be read in conjunction with the Companys annual consolidated financial statements included in the Companys annual report on Form 10-K for the year ended December 31, 2015. The results of operations for the nine months ended September 30, 2016 may not be indicative of the results to be expected for the year ending December 31, 2016.

Basic and Diluted Loss Per Share The Company computes basic loss per share by dividing net loss by the weighted-average number of common shares outstanding during the period. The Company computes diluted loss per share by dividing net loss by the sum of the weighted-average number of common shares outstanding and the weighted-average dilutive common share equivalents outstanding.  The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect.  As of September 30, 2016 and 2015, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:       <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="236" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:177pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> For the Three and Nine Months Ended</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="236" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:177pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Warrants to purchase shares</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Non-vested shares</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 10,871</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 505,634</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible debentures</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,204,068</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 3,076,923</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible notes</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,641,692</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr></table></div>

Recent Accounting Pronouncements   In February 2016, the Financial Accounting Standards Board (the FASB) issued Accounting Standards Update (ASU) No. 2016-02, Leases (ASU 2016-02). ASU 2016-02 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. ASU 2016-02 will be effective for the Companys fiscal year beginning January 1, 2019 on a modified retrospective basis and earlier adoption is permitted. Management is currently evaluating the impact of the pending adoption of ASU 2016-02 on the Companys consolidated financial statements.  In March 2016, the FASB issued ASU 2016-09, Stock Compensation (ASU 2016-09), which simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows.  ASU 2016-09 will be effective for annual periods beginning after December 15, 2016 and interim periods within those annual periods.  It is not anticipated that this update will have a material effect on the Companys consolidated financial statements

As of September 30, 2016 and 2015, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:       <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="236" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:177pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> For the Three and Nine Months Ended</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="236" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:177pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Warrants to purchase shares</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Non-vested shares</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 10,871</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 505,634</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible debentures</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,204,068</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 3,076,923</td></tr> <tr> <td valign="bottom" width="216" style='border-top:#f0f0f0;border-right:#f0f0f0;width:2.25in;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible notes</td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,641,692</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="110" style='border-top:#f0f0f0;border-right:#f0f0f0;width:82.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr></table></div>

Inventory consists of the following:   <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="434" style='width:325.2pt;border-collapse:collapse'> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> September 30,</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> December 31,</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2016</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2015</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Raw materials</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 93,792</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 76,925</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Work in progress</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 49,146</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 58,376</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Finished goods</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 251,144</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 106,595</td></tr> <tr style='height:3.5pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:3.5pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'>   Total inventory </td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 394,082</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 241,896</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Less carrying value of inventory not deemed to be a current asset </td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 358,908</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 206,722</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="220" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:165pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'>   Inventory, included in current assets </td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 35,174</td> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 35,174</td></tr></table></div>

Accrued liabilities consisted of the following:   <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="431" style='width:323pt;border-collapse:collapse'> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> September 30,</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> December 31,</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2016</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2015</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Accrued interest</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 203,798</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 115,627</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Accrued royalties</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 17,873</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 17,873</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Accrued payroll and payroll taxes</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 19,225</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 5,183</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="223" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:167pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Total accrued liabilities</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 240,896</td> <td valign="bottom" width="12" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:9pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 138,683</td></tr></table></div>

Short and Long-term debt is summarized as follows:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr align="left"> <td width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> December 31,</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018; $717,950 was converted to stock during the nine months ended September 30, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,282,050</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,000,000</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Convertible notes payable; unsecured; interest at 8.00% per annum; due November 6, 2020</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,206,931</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,206,931</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Note payable secured by all the assets of the Company; interest at 15.00% per annum; due June 30, 2018</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 189,389</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 189,389</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Note payable; interest at 10.00% per annum; due December 24, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 32,000</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Short term related party bridge loans; unsecured; interest at 8-10% per annum; due December 24, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 155,000</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Related-party note payable; interest at 8%; due August 31, 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 25,000</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Total long-term debt</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,865,370</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 3,421,320</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Less:  current portion</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 187,000</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 214,389</td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr align="left"> <td valign="bottom" width="337" style='border-top:#f0f0f0;border-right:#f0f0f0;width:252.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Long-term debt, net of current portion</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2,678,370</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 3,206,931</td></tr></table></div>

A summary of the status of the Companys non-vested shares as of September 30, 2016 and changes during the nine months then ended, is presented below:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Non-vested</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Shares of</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Weighted</td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Common</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Average</td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Stock</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Fair Value</td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Balance at December 31, 2015</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 253,670</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.50</td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Awarded</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Vested</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> (242,799)</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.50</td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="194" style='border-top:#f0f0f0;border-right:#f0f0f0;width:145.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Balance at September 30, 2016</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="94" style='border-top:#f0f0f0;border-right:#f0f0f0;width:70.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 10,871</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="92" style='border-top:#f0f0f0;border-right:#f0f0f0;width:69pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.50</td></tr></table></div>

Total stock-based compensation expense from all sources for the three and nine months ended September 30, 2016 and 2015, including stock-based compensation for the warrant discussed below in Note 6, has been included in the condensed consolidated statements of operations as follows:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="186" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:139.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> For the Three Months Ended</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="183" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:137.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> For the Nine Months Ended</td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="186" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:139.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="183" colspan="3" style='border-top:#f0f0f0;border-right:#f0f0f0;width:137.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> September 30,</td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2016</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 2015</td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Research and development expense</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 79,915</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 41,343</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 227,392</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 112,501</td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Selling, general and administrative expense</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 30,854</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 38,894</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 104,849</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 126,264</td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="254" style='border-top:#f0f0f0;border-right:#f0f0f0;width:190.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Total share-based compensation</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 110,769</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="82" style='border-top:#f0f0f0;border-right:#f0f0f0;width:61.5pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 80,237</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 332,241</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="81" style='border-top:#f0f0f0;border-right:#f0f0f0;width:60.75pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 238,765</td></tr></table></div>

A summary of warrant activity for the nine months ended September 30, 2016 is presented below:   <div align="center"> <table cellspacing="0" cellpadding="0" border="0"> <tr> <td width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td> <td width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'></td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Weighted</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Aggregate</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Weighted</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Average</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Intrinsic</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Shares</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Average</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Remaining</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Value of</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Under</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Exercise</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Contractual</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Vested</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Warrants</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Price</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Life</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Warrants</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Outstanding at December 31, 2015</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.54</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 7.3 years</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 213,364</td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Issued</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Exercised</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Expired</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 1pt solid;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> -</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td></tr> <tr> <td valign="bottom" width="226" style='border-top:#f0f0f0;border-right:#f0f0f0;width:169.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> Outstanding at September 30, 2016</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:black 2.25pt double;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,423,211</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 0.54</td> <td valign="bottom" width="14" style='border-top:#f0f0f0;border-right:#f0f0f0;width:10.5pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'>  </td> <td valign="bottom" width="83" style='border-top:#f0f0f0;border-right:#f0f0f0;width:62.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 6.6 years</td> <td valign="bottom" width="21" style='border-top:#f0f0f0;border-right:#f0f0f0;width:15.75pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> $</td> <td valign="bottom" width="75" style='border-top:#f0f0f0;border-right:#f0f0f0;width:56.25pt;border-bottom:#f0f0f0;padding-bottom:0in;padding-top:0in;padding-left:0in;border-left:#f0f0f0;padding-right:0in;background-color:transparent'> 1,055,257</td></tr></table></div>       Minimum lease commitments at September 30, 2016 for the remaining term of the lease are as follows:   <div align="center"> <table border="0" cellspacing="0" cellpadding="0" width="299" style='width:224.3pt;border-collapse:collapse'> <tr style='height:7.2pt'> <td valign="bottom" width="186" colspan="2" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:139.5pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Year ending September 30,</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 2017</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 39,397</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Thereafter</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> -</td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="92" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td></tr> <tr style='height:7.2pt'> <td valign="bottom" width="15" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:11.1pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'></td> <td valign="bottom" width="171" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:128.4pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> Total</td> <td valign="bottom" width="21" style='border-bottom:#f0f0f0;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:15.8pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> $</td> <td valign="bottom" width="92" style='border-bottom:windowtext 2.25pt double;border-left:#f0f0f0;padding-bottom:0cm;background-color:transparent;padding-left:5.4pt;width:69pt;padding-right:5.4pt;height:7.2pt;border-top:#f0f0f0;border-right:#f0f0f0;padding-top:0cm'> 39,397</td></tr></table></div> 1423211 1423211 10871 505634 2204068 3076923 1641692 93792 76925 49146 58376 251144 106595 394082 241896 358908 206722 35174 35174 10193 203798 115627 17873 17873 19225 5183 240896 138683 187000 185000 55000 599 189389 189389 0.1500 0.1500 21326 1012 333333 3500000 1.50 500000 5250000 333333 659038 882224 106334 65905 10000 1000 6478 1.34 0.402 0.0129 0.0170 1.2100 0.7100 4.5 5.2 0.0000 0.0000 10871 253670 0 -242799 0.50 0.50 0 0.50 10871 0.3 79915 41343 227392 112501 30854 38894 104849 126264 110769 80237 332241 238765 181190 50113 60905 21519 1.50 1423211 1423211 0 0 0 0.54 0.54 0 0 0 6.6 7.3 0 0 0 1055257 213364 70000 1.50 3940 0.0300 39397 0 39397 34917 36907 4750000 17873 17873 135000 88001 132002 8800 1282050 2000000 1206931 1206931 189389 189389 32000 155000 25000 2865370 3421320 187000 214389 2678370 3206931 10-Q 2016-09-30 false FRESH MEDICAL LABORATORIES, INC. 0001541884 fres --12-31 22810870 Smaller Reporting Company Yes No No 2016 Q3 717950 67217 1207951 332240 238765 29651 121400 0.0800 0.0800 0.1500 0.1000 0.0800 0.1000 0.0800 0001541884 2016-01-01 2016-09-30 0001541884 2016-11-14 0001541884 2016-09-30 0001541884 2015-12-31 0001541884 2016-07-01 2016-09-30 0001541884 2015-07-01 2015-09-30 0001541884 2015-01-01 2015-09-30 0001541884 2014-12-31 0001541884 2015-09-30 0001541884 2015-12-28 0001541884 2015-01-01 2015-12-31 0001541884 2016-01-02 shares iso4217:USD iso4217:USD shares pure EX-101.LAB 9 fres-20160930_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Stock Warrants Company issued shares of common stock at 0.65 per share Company issued shares of common stock at 0.65 per share The balance of accured interest The balance of accured interest Convertible notes interest per annum Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.. Note payable; interest at 10.00% per annum; due December 24, 2016 Note payable; interest at 10.00% per annum; due December 24, 2016 Company's Nonvested Shares Tabular disclosure of Company's Nonvested Shares as of June 30, 2012. Conversion of convertible debt and interest Conversion of convertible debt and interest Proceeds from related party debt Payments for property and equipment Payments for property and equipment Accrued Liabilities {1} Accrued Liabilities Subsequent transactions (Details) Lease Commitments Amount due based upon the occurrence of an event specified in the contractual terms. Outstanding Shares Under Warrants Outstanding Shares Under Warrants Total unrecognized compensation cost related to the non-vested stock-based compensation Vested Weighted Average Fair value Vested Non -vested Shares of Common stock Vested Non -vested Shares of Common stock Expected dividend yield Expected dividend yield Company was obligated under the terms of a master note to an individual related to an executive officer Company was obligated under the terms of a master note to an individual related to an executive officer Inventory Details Warrants to purchase shares of common stock Warrants to purchase shares of common stock Short and Long-term Debt Stock issued to placement agent Stock issued to placement agent Stockholders' Equity (Deficit): Accrued liabilities Entity Voluntary Filers Aggregate Intrinsic Value of Vested Warrants - Outstanding Weighted Average Remaining Contractual Life (years) - Expired Expired Shares Under Warrants Expired Shares Under Warrants Awarded Weighted Average Fair value Awarded Weighted Average Fair value Note payable to Relative of an Executive officer's interest rate per annum Company was obligated under the terms of a master note to an individual related to an executive officer Less: current portion Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Schedule of Warrants to purchase shares of common stock Basic and Diluted Loss Per Share Principles of Consolidation Organization The entire policy text block is about Organization. Common Stock Warrants Accrued liabilities. Inventory {2} Inventory Cash paid for income taxes Cash paid for interest Supplemental disclosure of cash flow information: Net increase (decrease) in cash Weighted-average common shares outstanding, basic and diluted Basic and diluted loss per share Additional paid-in capital Note Payable Current Liabilities Current Fiscal Year End Date Document Type Shares of common stock were issued to the placement agent Shares of common stock were issued to the placement agent Weighted Average Exercise Price - Outstanding Weighted Average Exercise Price - Outstanding Shares Under Warrants Vested Weighted Average Fair value Vested Weighted Average Fair value Expected volatility Expected volatility Common Stock Issued for Conversion of Debt Company incurred a commission liability to the Placement Agent Company incurred a commission liability to the Placement Agent Related party note interest and fee Related party note interest and fee Note payable; interest per annum Note payable; interest per annum Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018;$717,950 was converted to stock during the nine months ended September 30, 2016 Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018;$717,950 was converted to stock during the nine months ended September 30, 2016 Inventory consists of the following Schedule of Short and Long-term Debt {1} Schedule of Short and Long-term Debt Payments on notes payable Payments on notes payable Net cash flows from investing activities Accounts receivable Obsolete inventory Obsolete inventory Stock-based compensation Total other income (expense) Total other income (expense) Preferred stock, Shares authorized Related-party notes payable Amendment Flag Total Minimum lease commitments Total Minimum lease commitments Weighted Average Remaining Contractual Life (years) - Outstanding Weighted Average Remaining Contractual Life (years) - issued Weighted Average Exercise Price - Issued Weighted Average Exercise Price - Issued Issued Shares Under Warrants Outstanding Shares Under Warrants Selling, general and administrative expense {1} Selling, general and administrative expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Awarded Non -vested Shares of Common stock AwardedNonVestedSharesOfCommonStock1 Warrant Risk free interest Rate Warrant Risk free interest Rate Purchase price of share Purchase price of share Convertible debentures interest per annum Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Note payable secured by all the assets of the Company; interest at 15.00% per annum; Due June 30, 2018 Note payable secured by all the assets of the Company; interest at 15.00% per annum; due June 30, 2016 Cash at beginning of period Cash at beginning of period Cash at end of period Issuance of common stock for cash Net cash flows from operating activities Net cash flows from operating activities Change in assets and liabilities: Net loss Common stock, Outstanding Parentheticals Prepaid expenses Other Related Party Transactions Details Company incur a minimum development costs Weighted Average Remaining Contractual Life (years) The fair value of the Warrant was Company issued Company issued 19,767 shares of common stock with a total value to two consultants for services rendered Company issued Company issued 19,767 shares of common stock with a total value to two consultants for services rendered Common Stock Issued for Services Company received net proceeds from the offering Company received net proceeds from the offering Accrued interest Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Inventory, included in current assets Inventory, included in current assets Supplemental disclosure of non-cash investing and financing activities: Total Current Liabilities Total Current Assets Total Current Assets Entity Well-known Seasoned Issuer Payables and Accruals: Total accrued royalties under license agreement Total accrued royalties under license agreement Intrinsic value is calculated at per share Per share weighted average intrinsic value of equity-based compensation awards forfeited. Excludes stock and unit options Company is offering a minimum shares of common stock Company is offering a minimum shares of common stock Total long-term debt Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Accrued payroll and payroll taxes Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Inventory valued was written off due to obsolescence and is reported as cost of revenues nventory valued was written off due to obsolescence and is reported as cost of revenues Non-vested shares of common stock. Non-vested shares of common stock. Summary of Warrants Outstanding Tabular disclosure of warrants outstanding as of December 31, 2011 and June 30, 2012. Going Concern Inventory {1} Inventory Operating expenses: Revenues: Current Note Payable Cash Document Fiscal Year Focus Monthly rental payments under the non-cancelable lease in the third year Monthly rental payments under the non-cancelable lease in the third year Stock-based compensation expense from all sources Balance of Weighted Average Fair value Balance of Weighted Average Fair value Company recognized stock-based compensation related to the vesting of shares issued to directors, officers and consultants The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Obligated to issue the Placement Agent shares of common stock Obligated to issue the Placement Agent shares of common stock Company issued a note to a related-party Company issued a note to a related-party Short term related-party bridge loans unsecured interest at per annum minimum Short term related-party bridge loans unsecured interest at per annum minimum Note payable secured by all the assets interest at per annum Note payable secured by all the assets interest at per annum Short and Long-Term Debt Parentheticals Finished goods Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer Accrued Liabilities (Tables) Recent Accounting Pronouncements Common Stock {1} Common Stock Prepaid expenses {1} Prepaid expenses Total revenue Preferred stock, Outstanding Common stock, $0.001 par value; 40,000,000 shares authorized; 23,477,787 shares and 21,525,126 shares issued and outstanding, respectively Total Long-Term Liabilities Document Period End Date Entity Trading Symbol Company incur a minimum development costs Company incur a minimum development costs Weighted Average Exercise Price - Expired Weighted Average Exercise Price - Expired Cost is expected to be recognized over a weighted-average period in years Cost is expected to be recognized over a weighted-average period in years Offering. Legal fees Offering. Legal fees The Placement Agent will also receive an expense allowance of up to Company incurred a commission liability to the Placement Agent Inventory (Tables) {1} Inventory (Tables) Subsequent Events {1} Subsequent Events Provision for Doubtful Accounts Foreign currency exchange gain (loss), net Interest expense Interest expense Loss from operations Loss from operations Allowance for doubtul accounts of Accounts receivable Allowance for doubtul accounts of Accounts receivable Total Stockholders' Equity (Deficit) Liabilities and Stockholders' Equity (Deficit) Entity Public Float Lease expense charged to operations Lease expense charged to operations Minimum lease commitments Thereafter Minimum lease commitments Thereafter Weighted Average Remaining Contractual Life (years) - Exercised Weighted Average Remaining Contractual Life (years) - Exercised Related-Party Note payable and other Details Minimum lease commitments Minimum lease commitments Commitments and Contingencies {1} Commitments and Contingencies Basis of Presentation Short and Long-term Debt {1} Short and Long-term Debt Inventory. Total Assets Inventory Current Assets Entity Current Reporting Status Entity Filer Category Shares of common stock were issued Shares of common stock were issued Consulting agreements may be terminated the directors were paid a total Consulting agreements may be terminated the directors were paid a total Minimum lease commitments September 30, 2017 Minimum lease commitments September 30, 2017 Aggregate Intrinsic Value of Vested Warrants Expected life in years Expected life in years The Escrow Agent was paid for services in connection the Escrow Agent was paid for services in connection Total inventory Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Commitments and Contingencies Disclosure Payments on convertible notes payable Cash flows from investing activities: Stock issued for services Selling, general and administrative expense Preferred stock, Issued Convertible debentures Intangible assets, net of accumulated amortization Property and equipment, net of accumulated depreciation Inventory, noncurrent Assets {1} Assets License Agreement Company's common stock valued Per share CompanySCommonStockValuedPerShare1 Number of shares were subscribed Number of shares were subscribed Company is offering a maximum shares of Common stock Company is offering a maximum shares of Common stock Short term related party bridge loans; unsecured; interest at 8-10% per annum; due December 24, 2016 Note payable; interest at 10.00% per annum; due December 24, 2016 Summary of short and Long-term debt Accrued liabilities consisted of the following Warrants (Tables) Inventory (Tables) Subsequent Events Other Related Party Transactions {1} Other Related Party Transactions EX-101.PRE 10 fres-20160930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 11 fres-20160930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000390 - Statement - Summary of warrant activity during the period (Details) link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 000400 - Statement - Consulting Representation Agreement (Details) link:presentationLink link:definitionLink link:calculationLink 000260 - Statement - Inventory (Details) link:presentationLink link:definitionLink link:calculationLink 000310 - Statement - Note Payable to a Relative of an Executive Officer (Details) link:presentationLink link:definitionLink link:calculationLink 000450 - Statement - Subsequent transactions (Details) link:presentationLink link:definitionLink link:calculationLink 000420 - Statement - Lease Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 000360 - Statement - Total stock-based compensation expense (Details) link:presentationLink link:definitionLink link:calculationLink 000130 - Disclosure - Commitment and Contingencies link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 000370 - Statement - Stock Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 000200 - Disclosure - Schedule of Short and Long-term Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 000350 - Statement - Summary of the status of non-vested shares (Details) link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 400000 - Disclosure - Payables and Accruals link:presentationLink link:definitionLink link:calculationLink 000410 - Statement - New lease agreement (Details) link:presentationLink link:definitionLink link:calculationLink 000140 - Disclosure - Other Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - Common Stock Warrants link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 000270 - Statement - Accrued liabilities consisted of the following (Details) link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - Common Stock link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 000170 - Disclosure - Basic and Diluted Loss Per Share(Tables) link:presentationLink link:definitionLink link:calculationLink 000345 - Statement - Fair value of Warrant was estimated using the Black-Scholes option pricing model (Details) link:presentationLink link:definitionLink link:calculationLink 000240 - Statement - Basic and Diluted Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 000210 - Disclosure - Common Stock (Tables) link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000300 - Statement - Related-Party Note payable and other (Details) link:presentationLink link:definitionLink link:calculationLink 000290 - Statement - Short and Long-Term Debt Parentheticals (Details) link:presentationLink link:definitionLink link:calculationLink 000430 - Statement - License Agreement (Details) link:presentationLink link:definitionLink link:calculationLink 000340 - Statement - Common Stock (Details) link:presentationLink link:definitionLink link:calculationLink 000160 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 000220 - Disclosure - Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 000280 - Statement - Summary of Short and Long-term debt (Details) link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - Condensed Consolidated Balance Sheets Parentheticals link:presentationLink link:definitionLink link:calculationLink 000440 - Statement - Other Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 000060 - Disclosure - Organization and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 000180 - Disclosure - Inventory (Tables) link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - Short and Long-term Debt link:presentationLink link:definitionLink link:calculationLink 000230 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 000190 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 000330 - Statement - Private Placement of Common Stock of the Company (Details) link:presentationLink link:definitionLink link:calculationLink 000150 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 000250 - Statement - Inventory consists of the following (Details) link:presentationLink link:definitionLink link:calculationLink XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2016	Nov. 14, 2016
Document and Entity Information
Entity Registrant Name	FRESH MEDICAL LABORATORIES, INC.
Entity Trading Symbol	fres
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Entity Central Index Key	0001541884
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		22,810,870
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current Assets
Cash	$ 41,236	$ 451,526
Accounts receivable, net of allowance for doubtful accounts of $0 and $194,467, respectively		0
Inventory	35,174	35,174
Prepaid expenses	3,556	30,520
Total Current Assets	79,966	517,220
Inventory, noncurrent	358,908	206,722
Property and equipment, net of accumulated depreciation	88,823	106,541
Intangible assets, net of accumulated amortization	168,129	175,300
Total Assets	695,826	1,005,783
Current Liabilities
Accounts payable	328,155	97,849
Accrued liabilities	240,896	138,683
Related-party notes payable	155,000	25,000
Current Note Payable	32,000	189,389
Total Current Liabilities	756,051	450,921
Long-Term Liabilities
Note Payable	189,389
Convertible notes payable	1,206,931	1,206,931
Convertible debentures	1,282,050	2,000,000
Total Long-Term Liabilities	2,678,370	3,206,931
Total Liabilities	3,434,421	3,657,852
Stockholders' Equity (Deficit):
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding		0
Common stock, $0.001 par value; 40,000,000 shares authorized; 23,477,787 shares and 21,525,126 shares issued and outstanding, respectively	23,479	21,525
Additional paid-in capital	12,634,261	10,636,583
Accumulated deficit	(15,396,335)	(13,310,177)
Total Stockholders' Equity (Deficit)	(2,738,595)	(2,652,069)
Total Liabilities and Stockholders' Equity (Deficit)	$ 695,826	$ 1,005,783

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets Parentheticals - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Parentheticals
Allowance for doubtul accounts of Accounts receivable	$ 0	$ 194,467
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, Shares authorized	10,000,000	10,000,000
Preferred stock, Issued	0	0
Preferred stock, Outstanding	$ 0	$ 0
Common stock, par value	$ 0.001	$ 0.001
Common stock, Shares authorized	40,000,000	40,000,000
Common stock, Issued	23,477,787	21,525,126
Common stock, Outstanding	$ 23,477,787	$ 21,525,126

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues:
Revenue		$ 10,450		$ 19,450
Total revenue		10,450		19,450
Cost of revenue		7,763	$ 10,193	15,563
Gross margin		2,687	(10,193)	3,887
Operating expenses:
Research and development expense	$ 241,809	389,851	806,052	877,552
Selling, general and administrative expense	360,172	398,218	1,065,631	836,974
Total operating expenses	601,981	788,069	1,871,683	1,714,526
Loss from operations	(601,981)	(785,382)	(1,881,876)	(1,710,639)
Other income (expense):
Interest expense	(65,526)	(79,004)	(204,282)	(193,412)
Foreign currency exchange gain (loss), net		(2,331)		(22,287)
Total other income (expense)	(65,526)	(81,335)	(204,282)	(215,699)
Net loss	$ (667,507)	$ (866,717)	$ (2,086,158)	$ (1,926,338)
Basic and diluted loss per share	$ (0.03)	$ (0.04)	$ (0.09)	$ (0.1)
Weighted-average common shares outstanding, basic and diluted	22,964,764	20,448,611	22,349,903	20,013,387

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (2,086,158)	$ (1,926,338)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation & Amortization	24,889	6,767
Stock-based compensation	302,590	238,765
Obsolete inventory	10,193
Stock issued for services	29,651
Provision for Doubtful Accounts		47,815
Change in assets and liabilities:
Accounts receivable		50,711
Inventory	(162,379)	1,092
Prepaid expenses	26,964	5,384
Accounts payable	230,306	(6,235)
Accrued Liabilities	169,430	(121,560)
Net cash flows from operating activities	(1,454,514)	(1,703,599)
Cash flows from investing activities:
Payments for property and equipment		(62,619)
Net cash flows from investing activities		(62,619)
Cash flows from financing activities:
Issuance of common stock for cash	882,224	807,960
Proceeds from issuance of convertible debentures		2,000,000
Payments on convertible notes payable		(40,000)
Payments on notes payable		(29,536)
Proceeds from notes payable	32,000
Proceeds from related party debt	185,000
Payments on related party debt	(55,000)
Net cash flows from financing activities	1,044,224	2,738,424
Net increase (decrease) in cash	(410,290)	972,206
Cash at beginning of period	451,526	4,044
Cash at end of period	41,236	976,250
Supplemental disclosure of cash flow information:
Cash paid for interest	48,744	309,658
Cash paid for income taxes		0
Supplemental disclosure of non-cash investing and financing activities:
Conversion of convertible debt and interest	785,167	$ 61,935
Stock issued to placement agent	$ 66

XML 17 R6.htm IDEA: XBRL DOCUMENT

Organization and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2016

Organization and Summary of Significant Accounting Policies

Organization and Summary of Significant Accounting Policies

Note 1 – Organization and Summary of Significant Accounting Policies


	For the Three and Nine Months Ended
	September 30,
	2016	2015
Warrants to purchase shares	1,423,211	1,423,211
Non-vested shares	10,871	505,634
Convertible debentures	2,204,068	3,076,923
Convertible notes	1,641,692	-

Recent Accounting Pronouncements –

XML 18 R7.htm IDEA: XBRL DOCUMENT

Inventory

9 Months Ended

Sep. 30, 2016

Inventory.

Inventory

Note 2 – Inventory

		September 30,		December 31,
		2016		2015

Raw materials	$	93,792	$	76,925
Work in progress		49,146		58,376
Finished goods		251,144		106,595

Total inventory		394,082		241,896

Less carrying value of inventory not deemed to be a current asset		358,908		206,722

Inventory, included in current assets	$	35,174	$	35,174

XML 19 R8.htm IDEA: XBRL DOCUMENT

Accrued Liabilities

9 Months Ended

Sep. 30, 2016

Accrued liabilities.

Accrued Liabilities

Note 3 – Accrued Liabilities

Accrued liabilities consisted of the following:

		September 30,		December 31,
		2016		2015

Accrued interest	$	203,798	$	115,627
Accrued royalties		17,873		17,873
Accrued payroll and payroll taxes		19,225		5,183

Total accrued liabilities	$	240,896	$	138,683

XML 20 R9.htm IDEA: XBRL DOCUMENT

Short and Long-term Debt

9 Months Ended

Sep. 30, 2016

Short and Long-term Debt

Short and Long-term Debt

Note 4 –Short and Long-term Debt

Short and Long-term debt is summarized as follows:


		September 30,		December 31,
		2016		2015

Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018; $717,950 was converted to stock during the nine months ended September 30, 2016	$	1,282,050	$	2,000,000

Convertible notes payable; unsecured; interest at 8.00% per annum; due November 6, 2020		1,206,931		1,206,931

Note payable secured by all the assets of the Company; interest at 15.00% per annum; due June 30, 2018		189,389		189,389

Note payable; interest at 10.00% per annum; due December 24, 2016		32,000		-

Short term related party bridge loans; unsecured; interest at 8-10% per annum; due December 24, 2016		155,000		-

Related-party note payable; interest at 8%; due August 31, 2016		-		25,000

Total long-term debt		2,865,370		3,421,320

Less: current portion		187,000		214,389

Long-term debt, net of current portion	$	2,678,370	$	3,206,931

During the nine months ended , notes totaling $187,000 were due. Subsequent to September 30, 2016. these notes were extended until December 24, 2016.

Related-Party Note payable

Note Payable to a Relative of an Executive Officer

XML 21 R10.htm IDEA: XBRL DOCUMENT

Common Stock

9 Months Ended

Sep. 30, 2016

Common Stock

Common Stock

Note 5 – Common Stock

Private Placement of Common Stock of the Company

Common Stock Issued for Conversion of Debt

Common Stock Issued for Services

In addition, during the nine months ended September 30, 2016, the Company issued 19,767 shares of common stock with a total value of $29,651 to two consultants for services rendered.

The Company recognized stock-based compensation related to the shares issued to directors, officers and consultants for the nine months ended September 30, 2016 and 2015 of $332,241 and $238,765, respectively. A summary of the status of the Company’s non-vested shares as of September 30, 2016 and changes during the nine months then ended, is presented below:


	Non-vested
	Shares of		Weighted
	Common		Average
	Stock		Fair Value

Balance at December 31, 2015	253,670	$	0.50
Awarded	-		-
Vested	(242,799)		0.50

Balance at September 30, 2016	10,871	$	0.50


		For the Three Months Ended				For the Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015

Research and development expense	$	79,915	$	41,343	$	227,392	$	112,501
Selling, general and administrative expense		30,854		38,894		104,849		126,264

Total share-based compensation	$	110,769	$	80,237	$	332,241	$	238,765

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Common Stock Warrants

9 Months Ended

Sep. 30, 2016

Common Stock Warrants

Common Stock Warrants

Note 6 – Common Stock Warrants

A summary of warrant activity for the nine months ended September 30, 2016 is presented below:


				Weighted		Aggregate
			Weighted	Average		Intrinsic
	Shares		Average	Remaining		Value of
	Under		Exercise	Contractual		Vested
	Warrants		Price	Life		Warrants

Outstanding at December 31, 2015	1,423,211	$	0.54	7.3 years	$	213,364
Issued	-		-
Exercised	-		-
Expired	-		-

Outstanding at September 30, 2016	1,423,211	$	0.54	6.6 years	$	1,055,257

XML 23 R12.htm IDEA: XBRL DOCUMENT

Commitment and Contingencies

9 Months Ended

Sep. 30, 2016

Commitment and Contingencies:

Commitments and Contingencies Disclosure

Note 7 – Commitments and Contingencies

Consulting Representation Agreement

Minimum lease commitments at September 30, 2016 for the remaining term of the lease are as follows:

Year ending September 30,
	2017	$	39,397
	Thereafter		-

	Total	$	39,397

Lease expense charged to operations related to this agreement for the nine months ended September 30, 2016 and 2015 was $34,917 and $36,907, respectively.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Other Related Party Transactions

9 Months Ended

Sep. 30, 2016

Other Related Party Transactions

Other Related Party Transactions

Note 8 – Other Related Party Transactions

XML 25 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Sep. 30, 2016

Subsequent Events

Subsequent Events

Note 9 – Subsequent Events

Subsequent to September 30, 2016, 88,001 shares of common stock were issued for $132,002 cash as well as 8,800 shares of common stock were issued to the placement agent.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Organization and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2016

Organization and Summary of Significant Accounting Policies (Policies)

Organization

Principles of Consolidation

Going Concern

Basis of Presentation

Basic and Diluted Loss Per Share


	For the Three and Nine Months Ended
	September 30,
	2016	2015
Warrants to purchase shares	1,423,211	1,423,211
Non-vested shares	10,871	505,634
Convertible debentures	2,204,068	3,076,923
Convertible notes	1,641,692	-

Recent Accounting Pronouncements

Recent Accounting Pronouncements –

XML 27 R16.htm IDEA: XBRL DOCUMENT

Basic and Diluted Loss Per Share(Tables)

9 Months Ended

Sep. 30, 2016

Basic and Diluted Loss Per Share {1}

Schedule of Warrants to purchase shares of common stock

As of September 30, 2016 and 2015, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:


	For the Three and Nine Months Ended
	September 30,
	2016	2015
Warrants to purchase shares	1,423,211	1,423,211
Non-vested shares	10,871	505,634
Convertible debentures	2,204,068	3,076,923
Convertible notes	1,641,692	-

XML 28 R17.htm IDEA: XBRL DOCUMENT

Inventory (Tables)

9 Months Ended

Sep. 30, 2016

Inventory (Tables)

Inventory (Tables)

Inventory consists of the following:

		September 30,		December 31,
		2016		2015

Raw materials	$	93,792	$	76,925
Work in progress		49,146		58,376
Finished goods		251,144		106,595

Total inventory		394,082		241,896

Less carrying value of inventory not deemed to be a current asset		358,908		206,722

Inventory, included in current assets	$	35,174	$	35,174

XML 29 R18.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2016

Accrued Liabilities (Tables)

Accrued Liabilities

Accrued liabilities consisted of the following:

		September 30,		December 31,
		2016		2015

Accrued interest	$	203,798	$	115,627
Accrued royalties		17,873		17,873
Accrued payroll and payroll taxes		19,225		5,183

Total accrued liabilities	$	240,896	$	138,683

XML 30 R19.htm IDEA: XBRL DOCUMENT

Schedule of Short and Long-term Debt (Tables)

9 Months Ended

Sep. 30, 2016

Schedule of Short and Long-term Debt

Schedule of Short and Long-term Debt

Short and Long-term debt is summarized as follows:


		September 30,		December 31,
		2016		2015

Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018; $717,950 was converted to stock during the nine months ended September 30, 2016	$	1,282,050	$	2,000,000

Convertible notes payable; unsecured; interest at 8.00% per annum; due November 6, 2020		1,206,931		1,206,931

Note payable secured by all the assets of the Company; interest at 15.00% per annum; due June 30, 2018		189,389		189,389

Note payable; interest at 10.00% per annum; due December 24, 2016		32,000		-

Short term related party bridge loans; unsecured; interest at 8-10% per annum; due December 24, 2016		155,000		-

Related-party note payable; interest at 8%; due August 31, 2016		-		25,000

Total long-term debt		2,865,370		3,421,320

Less: current portion		187,000		214,389

Long-term debt, net of current portion	$	2,678,370	$	3,206,931

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

XML 31 R20.htm IDEA: XBRL DOCUMENT

Common Stock (Tables)

9 Months Ended

Sep. 30, 2016

Common Stock (Tables)

Company's Nonvested Shares

A summary of the status of the Company’s non-vested shares as of September 30, 2016 and changes during the nine months then ended, is presented below:


	Non-vested
	Shares of		Weighted
	Common		Average
	Stock		Fair Value

Balance at December 31, 2015	253,670	$	0.50
Awarded	-		-
Vested	(242,799)		0.50

Balance at September 30, 2016	10,871	$	0.50

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan


		For the Three Months Ended				For the Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015

Research and development expense	$	79,915	$	41,343	$	227,392	$	112,501
Selling, general and administrative expense		30,854		38,894		104,849		126,264

Total share-based compensation	$	110,769	$	80,237	$	332,241	$	238,765

XML 32 R21.htm IDEA: XBRL DOCUMENT

Warrants (Tables)

9 Months Ended

Sep. 30, 2016

Warrants (Tables)

Summary of Warrants Outstanding

A summary of warrant activity for the nine months ended September 30, 2016 is presented below:


				Weighted		Aggregate
			Weighted	Average		Intrinsic
	Shares		Average	Remaining		Value of
	Under		Exercise	Contractual		Vested
	Warrants		Price	Life		Warrants

Outstanding at December 31, 2015	1,423,211	$	0.54	7.3 years	$	213,364
Issued	-		-
Exercised	-		-
Expired	-		-

Outstanding at September 30, 2016	1,423,211	$	0.54	6.6 years	$	1,055,257

XML 33 R22.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2016

Commitments and Contingencies {1}

Minimum lease commitments

Minimum lease commitments at September 30, 2016 for the remaining term of the lease are as follows:

Year ending September 30,
	2017	$	39,397
	Thereafter		-

	Total	$	39,397

XML 34 R23.htm IDEA: XBRL DOCUMENT

Basic and Diluted Loss Per Share (Details) - USD ($)	3 Months Ended	9 Months Ended
Basic and Diluted Loss Per Share (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Basic and Diluted Loss Per Share (Details)
Warrants to purchase shares of common stock	1,423,211	1,423,211
Non-vested shares of common stock.	10,871	505,634
Convertible debentures	$ 2,204,068	$ 3,076,923
Convertible notes payable	$ 1,641,692

XML 35 R24.htm IDEA: XBRL DOCUMENT

Inventory consists of the following (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Inventory consists of the following
Raw materials	$ 93,792	$ 76,925
Work in progress	49,146	58,376
Finished goods	251,144	106,595
Total inventory	394,082	241,896
Less carrying value of inventory not deemed to be a current asset	358,908	206,722
Inventory, included in current assets	$ 35,174	$ 35,174

XML 36 R25.htm IDEA: XBRL DOCUMENT

Inventory (Details)	9 Months Ended
Inventory (Details)	Sep. 30, 2016 USD ($)
Inventory Details
Inventory valued was written off due to obsolescence and is reported as cost of revenues	$ 10,193

XML 37 R26.htm IDEA: XBRL DOCUMENT

Accrued liabilities consisted of the following (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Accrued liabilities consisted of the following
Accrued interest	$ 203,798	$ 115,627
Accrued royalties	17,873	17,873
Accrued payroll and payroll taxes	19,225	5,183
Total accrued liabilities	$ 240,896	$ 138,683

XML 38 R27.htm IDEA: XBRL DOCUMENT

Summary of Short and Long-term debt (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Summary of short and Long-term debt
Convertible debentures; unsecured; interest at 8.00% per annum; due May 1, 2018;$717,950 was converted to stock during the nine months ended September 30, 2016	$ 1,282,050	$ 2,000,000
Convertible notes payable; unsecured; interest at 8.00% per annum; due November 6, 2020	1,206,931	1,206,931
Note payable secured by all the assets of the Company; interest at 15.00% per annum; Due June 30, 2018	189,389	189,389
Note payable; interest at 10.00% per annum; due December 24, 2016	32,000
Short term related party bridge loans; unsecured; interest at 8-10% per annum; due December 24, 2016	155,000
Related-party note payable; interest at 8%; due August 31, 2016		25,000
Total long-term debt	2,865,370	3,421,320
Less: current portion	187,000	214,389
Long-term debt, net of current portion	$ 2,678,370	$ 3,206,931

XML 39 R28.htm IDEA: XBRL DOCUMENT

Short and Long-Term Debt Parentheticals (Details)	Sep. 30, 2016
Short and Long-Term Debt Parentheticals
Convertible debentures interest per annum	8.00%
Convertible notes interest per annum	8.00%
Note payable secured by all the assets interest at per annum	15.00%
Note payable; interest per annum	10.00%
Short term related-party bridge loans unsecured interest at per annum minimum	8.00%
Short term related-party bridge loans unsecured interest at per annum maximum	10.00%
Related-party note payable interest per annum	8.00%

XML 40 R29.htm IDEA: XBRL DOCUMENT

Related-Party Note payable and other (Details)	9 Months Ended
Related-Party Note payable and other (Details)	Sep. 30, 2016 USD ($)
Related-Party Note payable and other Details
Notes totaling	$ 187,000
Company issued a note to a related-party	185,000
Company repaid notes to related - parties	55,000
Related party note interest and fee	$ 599

XML 41 R30.htm IDEA: XBRL DOCUMENT

Note Payable to a Relative of an Executive Officer (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Note Payable to a Relative of an Executive Officer Details
Company was obligated under the terms of a master note to an individual related to an executive officer	$ 189,389	$ 189,389
Note payable to Relative of an Executive officer's interest rate per annum	15.00%	15.00%
The balance of accured interest	$ 21,326	$ 1,012

XML 42 R31.htm IDEA: XBRL DOCUMENT

Private Placement of Common Stock of the Company (Details) - USD ($)	Sep. 30, 2016	Dec. 28, 2015
Private Placement of Common Stock details
Company is offering a minimum shares of common stock		333,333
Company is offering a maximum shares of Common stock		3,500,000
Purchase price of share		$ 1.50
Minimum offering amount for minimum shares		$ 500,000
Maximum offering amount for maximum shares		$ 5,250,000
The offering proceeds were being deposited into an escrow account until a minimum of shares were sold for cash		333,333
Number of shares were subscribed	659,038
Company received net proceeds from the offering	$ 882,224
Company incurred a commission liability to the Placement Agent	106,334
Obligated to issue the Placement Agent shares of common stock	65,905
The Placement Agent will also receive an expense allowance of up to	10,000
The Escrow Agent was paid for services in connection	1,000
Offering. Legal fees	$ 6,478

XML 43 R32.htm IDEA: XBRL DOCUMENT

Common Stock (Details) - USD ($)	9 Months Ended
Common Stock (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Common Stock Issued for Conversion of Debt
Convertible debenture holders exercised their right and converted of Principal amount into common stock	717,950
Accured interest converted into common stock	$ 67,217
Company issued shares of common stock at 0.65 per share	1,207,951
Common Stock Issued for Services
Company recognized stock-based compensation related to the vesting of shares issued to directors, officers and consultants	$ 332,240	$ 238,765
Company issued Company issued 19,767 shares of common stock with a total value to two consultants for services rendered	29,651
Company recognized in stock compensation expense related to the amortization of this deferred compensation	$ 121,400

XML 44 R33.htm IDEA: XBRL DOCUMENT

Fair value of Warrant was estimated using the Black-Scholes option pricing model (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
The fair value of the Warrant was
Fair value of Warrant per share	$ 1.34	$ 0.402
Warrant Risk free interest Rate	1.29%	1.70%
Expected volatility	121.00%	71.00%
Expected life in years	4.5	5.2
Expected dividend yield	0.00%	0.00%

XML 45 R34.htm IDEA: XBRL DOCUMENT

Summary of the status of non-vested shares (Details)	Sep. 30, 2016 USD ($) $ / shares shares	Dec. 31, 2015 $ / shares shares
Summary of the status of the Company's non-vested shares Details
Balance of non vested shares of common stock \| shares	10,871	253,670
Awarded Non -vested Shares of Common stock \| shares	0
Vested Non -vested Shares of Common stock \| shares	(242,799)
Balance of Weighted Average Fair value \| $ / shares	$ 0.50	$ 0.50
Awarded Weighted Average Fair value \| $ / shares	0
Vested Weighted Average Fair value \| $ / shares	$ 0.50
Total unrecognized compensation cost related to the non-vested stock-based compensation \| $	$ 10,871
Cost is expected to be recognized over a weighted-average period in years	0.3

XML 46 R35.htm IDEA: XBRL DOCUMENT

Total stock-based compensation expense (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Stock-based compensation expense from all sources
Research and development expense	$ 79,915	$ 41,343	$ 227,392	$ 112,501
Selling, general and administrative expense	30,854	38,894	104,849	126,264
Total share-based compensation	$ 110,769	$ 80,237	$ 332,241	$ 238,765

XML 47 R36.htm IDEA: XBRL DOCUMENT

Stock Warrants (Details) - USD ($)	3 Months Ended		9 Months Ended
Stock Warrants (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Stock Warrants
Company recognized as share-based compensation and additional paid-in capital related to the vesting of warrant shares	$ 60,905	$ 21,519	$ 181,190	$ 50,113
Intrinsic value is calculated at per share	$ 1.50

XML 48 R37.htm IDEA: XBRL DOCUMENT

Summary of warrant activity during the period (Details)	Sep. 30, 2016 USD ($) $ / shares shares	Dec. 31, 2015 USD ($) $ / shares shares
Shares Under Warrants
Outstanding Shares Under Warrants \| shares	1,423,211	1,423,211
Issued Shares Under Warrants \| shares	0
Exercised Shares Under Warrants \| shares	0
Expired Shares Under Warrants \| shares	0
Weighted Average Exercise Price
Weighted Average Exercise Price - Outstanding \| $ / shares	$ 0.54	$ 0.54
Weighted Average Exercise Price - Issued \| $ / shares	0
Weighted Average Exercise Price - Exercised \| $ / shares	0
Weighted Average Exercise Price - Expired \| $ / shares	$ 0
Weighted Average Remaining Contractual Life (years)
Weighted Average Remaining Contractual Life (years) - Outstanding	6.6	7.3
Weighted Average Remaining Contractual Life (years) - issued	0
Weighted Average Remaining Contractual Life (years) - Exercised	0
Weighted Average Remaining Contractual Life (years) - Expired	0
Aggregate Intrinsic Value of Vested Warrants
Aggregate Intrinsic Value of Vested Warrants - Outstanding \| $	$ 1,055,257	$ 213,364

XML 49 R38.htm IDEA: XBRL DOCUMENT

Consulting Representation Agreement (Details)	Jan. 02, 2016 USD ($) $ / shares
consulting Representation Agreement Details
Company is obligated to pay the consultants per calendar quarter for the expenses. \| $	$ 70,000
Company's common stock valued Per share \| $ / shares	$ 1.50

XML 50 R39.htm IDEA: XBRL DOCUMENT

New lease agreement (Details)	Sep. 30, 2016 USD ($)
New lease agreement
Monthly rental payments under the non-cancelable lease in the third year	$ 3,940
Percentage of escalation per year during the additional term	3.00%

XML 51 R40.htm IDEA: XBRL DOCUMENT

Lease Commitments (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Lease Commitments
Minimum lease commitments September 30, 2017	$ 39,397
Minimum lease commitments Thereafter	0
Total Minimum lease commitments	39,397
Lease expense charged to operations	$ 34,917	$ 36,907

XML 52 R41.htm IDEA: XBRL DOCUMENT

License Agreement (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
License Agreement
Company incur a minimum development costs			$ 4,750,000
Total accrued royalties under license agreement	$ 17,873	$ 17,873

XML 53 R42.htm IDEA: XBRL DOCUMENT

Other Related Party Transactions (Details)	9 Months Ended
Other Related Party Transactions (Details)	Sep. 30, 2016 USD ($)
Other Related Party Transactions Details
Consulting agreements may be terminated the directors were paid a total	$ 135,000

XML 54 R43.htm IDEA: XBRL DOCUMENT

Subsequent transactions (Details)	Sep. 30, 2016 USD ($) shares
Subsequent transactions (Details)
Shares of common stock were issued	88,001
Shares of common stock were issued for cash \| $	$ 132,002
Shares of common stock were issued to the placement agent	8,800

XML 55 R44.htm IDEA: XBRL DOCUMENT

Payables and Accruals	Sep. 30, 2016 USD ($)
Payables and Accruals:
Related-party notes payable	$ 0

EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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®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

XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 12 216 1 false 0 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.freshmedicals.com/20160930/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.freshmedicals.com/20160930/role/idr_CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 000030 - Statement - Condensed Consolidated Balance Sheets Parentheticals Sheet http://www.freshmedicals.com/20160930/role/idr_CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets Parentheticals Statements 3 false false R4.htm 000040 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.freshmedicals.com/20160930/role/idr_CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 000050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.freshmedicals.com/20160930/role/idr_CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 000060 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies Organization and Summary of Significant Accounting Policies Notes 6 false false R7.htm 000070 - Disclosure - Inventory Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureInventory Inventory Notes 7 false false R8.htm 000080 - Disclosure - Accrued Liabilities Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureAccruedLiabilities Accrued Liabilities Notes 8 false false R9.htm 000090 - Disclosure - Short and Long-term Debt Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureShortAndLongTermDebt Short and Long-term Debt Notes 9 false false R10.htm 000110 - Disclosure - Common Stock Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureCommonStock Common Stock Notes 10 false false R11.htm 000120 - Disclosure - Common Stock Warrants Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureCommonStockWarrants Common Stock Warrants Notes 11 false false R12.htm 000130 - Disclosure - Commitment and Contingencies Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureCommitmentAndContingencies Commitment and Contingencies Notes 12 false false R13.htm 000140 - Disclosure - Other Related Party Transactions Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureOtherRelatedPartyTransactions Other Related Party Transactions Notes 13 false false R14.htm 000150 - Disclosure - Subsequent Events Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureSubsequentEvents Subsequent Events Notes 14 false false R15.htm 000160 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://www.freshmedicals.com/20160930/role/idr_DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies 15 false false R16.htm 000170 - Disclosure - Basic and Diluted Loss Per Share(Tables) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureBasicAndDilutedLossPerShareTables Basic and Diluted Loss Per Share(Tables) Tables 16 false false R17.htm 000180 - Disclosure - Inventory (Tables) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureInventoryTables Inventory (Tables) Tables http://www.freshmedicals.com/20160930/role/idr_DisclosureInventory 17 false false R18.htm 000190 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureAccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.freshmedicals.com/20160930/role/idr_DisclosureAccruedLiabilities 18 false false R19.htm 000200 - Disclosure - Schedule of Short and Long-term Debt (Tables) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureScheduleOfShortAndLongTermDebtTables Schedule of Short and Long-term Debt (Tables) Tables 19 false false R20.htm 000210 - Disclosure - Common Stock (Tables) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureCommonStockTables Common Stock (Tables) Tables http://www.freshmedicals.com/20160930/role/idr_DisclosureCommonStock 20 false false R21.htm 000220 - Disclosure - Warrants (Tables) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureWarrantsTables Warrants (Tables) Tables 21 false false R22.htm 000230 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables 22 false false R23.htm 000240 - Statement - Basic and Diluted Loss Per Share (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_BasicAndDilutedLossPerShareDetails Basic and Diluted Loss Per Share (Details) Details http://www.freshmedicals.com/20160930/role/idr_DisclosureBasicAndDilutedLossPerShareTables 23 false false R24.htm 000250 - Statement - Inventory consists of the following (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_InventoryConsistsOfTheFollowingDetails Inventory consists of the following (Details) Details 24 false false R25.htm 000260 - Statement - Inventory (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_InventoryDetails Inventory (Details) Details http://www.freshmedicals.com/20160930/role/idr_DisclosureInventoryTables 25 false false R26.htm 000270 - Statement - Accrued liabilities consisted of the following (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_AccruedLiabilitiesConsistedOfTheFollowingDetails Accrued liabilities consisted of the following (Details) Details 26 false false R27.htm 000280 - Statement - Summary of Short and Long-term debt (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_SummaryOfShortAndLongTermDebtDetails Summary of Short and Long-term debt (Details) Details 27 false false R28.htm 000290 - Statement - Short and Long-Term Debt Parentheticals (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_ShortAndLongTermDebtParentheticalsDetails Short and Long-Term Debt Parentheticals (Details) Details 28 false false R29.htm 000300 - Statement - Related-Party Note payable and other (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_RelatedPartyNotePayableAndOtherDetails Related-Party Note payable and other (Details) Details 29 false false R30.htm 000310 - Statement - Note Payable to a Relative of an Executive Officer (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_NotePayableToARelativeOfAnExecutiveOfficerDetails Note Payable to a Relative of an Executive Officer (Details) Details 30 false false R31.htm 000330 - Statement - Private Placement of Common Stock of the Company (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_PrivatePlacementOfCommonStockOfTheCompanyDetails Private Placement of Common Stock of the Company (Details) Details 31 false false R32.htm 000340 - Statement - Common Stock (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_CommonStockDetails Common Stock (Details) Details http://www.freshmedicals.com/20160930/role/idr_DisclosureCommonStockTables 32 false false R33.htm 000345 - Statement - Fair value of Warrant was estimated using the Black-Scholes option pricing model (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_FairValueOfWarrantWasEstimatedUsingTheBlackScholesOptionPricingModelDetails Fair value of Warrant was estimated using the Black-Scholes option pricing model (Details) Details 33 false false R34.htm 000350 - Statement - Summary of the status of non-vested shares (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_SummaryOfTheStatusOfNonVestedSharesDetails Summary of the status of non-vested shares (Details) Details 34 false false R35.htm 000360 - Statement - Total stock-based compensation expense (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_TotalStockBasedCompensationExpenseDetails Total stock-based compensation expense (Details) Details 35 false false R36.htm 000370 - Statement - Stock Warrants (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_StockWarrantsDetails Stock Warrants (Details) Details 36 false false R37.htm 000390 - Statement - Summary of warrant activity during the period (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_SummaryOfWarrantActivityDuringThePeriodDetails Summary of warrant activity during the period (Details) Details 37 false false R38.htm 000400 - Statement - Consulting Representation Agreement (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_ConsultingRepresentationAgreementDetails Consulting Representation Agreement (Details) Details 38 false false R39.htm 000410 - Statement - New lease agreement (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_NewLeaseAgreementDetails New lease agreement (Details) Details 39 false false R40.htm 000420 - Statement - Lease Commitments (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_LeaseCommitmentsDetails Lease Commitments (Details) Details 40 false false R41.htm 000430 - Statement - License Agreement (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_LicenseAgreementDetails License Agreement (Details) Details 41 false false R42.htm 000440 - Statement - Other Related Party Transactions (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_OtherRelatedPartyTransactionsDetails Other Related Party Transactions (Details) Details http://www.freshmedicals.com/20160930/role/idr_DisclosureOtherRelatedPartyTransactions 42 false false R43.htm 000450 - Statement - Subsequent transactions (Details) Sheet http://www.freshmedicals.com/20160930/role/idr_SubsequentTransactionsDetails Subsequent transactions (Details) Details 43 false false R44.htm 400000 - Disclosure - Payables and Accruals Sheet http://www.freshmedicals.com/20160930/role/idr_DisclosurePayablesAndAccruals Payables and Accruals Uncategorized 44 false false All Reports Book All Reports fres-20160930.xml fres-20160930.xsd fres-20160930_cal.xml fres-20160930_def.xml fres-20160930_lab.xml fres-20160930_pre.xml true true ZIP 62 0001078782-16-003778-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001078782-16-003778-xbrl.zip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end